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ABSTRACT 
Cells use complex mechanisms to regulate glucose transport and metabolism to 
achieve optimal energy and biomass production while avoiding accumulation of toxic 
metabolites.  Glucose transport and glycolytic metabolism carries the risk of the buildup 
of phosphosugars, which can inhibit growth at high concentrations.  Many enteric 
bacteria cope with phosphosugar accumulation and associated stress (i.e., phosphosugar 
stress) by producing a small RNA (sRNA) regulator, SgrS, which represses translation of 
sugar transporter mRNAs (ptsG and manXYZ) and enhances translation of a sugar 
phosphatase mRNA (yigL).  Despite a molecular understanding of individual target 
regulation by SgrS, previously little was known about how coordinated regulation of 
these targets contributes to the rescue of cell growth during phosphosugar stress.  The 
first part of my graduate study examines how SgrS regulation of different targets impacts 
growth under different nutritional conditions upon phosphosugar stress.  The severity of 
stress-associated growth inhibition depended on nutrient availability.  Cells that were 
stressed during growth in rich media required SgrS regulation of sugar transporter 
mRNAs (ptsG or manXYZ).  However, repression of transporter mRNAs was insufficient 
for growth rescue during stress in nutrient-poor minimal media; here SgrS regulation of 
the phosphatase (yigL) and as-yet-undefined targets also contributed to growth rescue.  
These results suggest that SgrS and perhaps other sRNAs are flexible regulators that 
modulate expression of multi-gene regulons in order to allow cells to adapt to an array of 
stress conditions.  Moreover, regulation of only a subset of an sRNAs targets may be 
important in a given environment.   
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The gene located directly downstream of sgrS is setA, and the gene organization 
of sgrR, sgrS and setA is conserved in numerous enteric species, prompting the 
hypothesis that SetA contributes to the glucose-phosphate stress response.  SetA is a 
proton motive force-driven efflux pump capable of transporting various sugars and sugar 
analogs in vitro.  The second part of my graduate study shows that setA expression is 
induced in response to glucose-phosphate stress, and this requires SgrR.  Under stress 
conditions, setA is cotranscribed with sgrS from the sgrS promoter.  A setA mutant 
exhibits a growth defect under stress conditions that can be complemented by setA in 
trans, suggesting that SetA contributes to the optimal cellular recovery from stress.  
Despite previous in vitro evidence that SetA can promote efflux of the stress-causing 
glucose analog α-methyl glucoside, in vivo data in this study indicate that SetA is not the 
major efflux pump responsible for removal of α-methyl glucoside under stress 
conditions. 
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CHAPTER 1:  INTRODUCTION 
1.1 Escherichia coli 
1.1.1 Overview 
Escherichia coli was first isolated by the German pediatrician Theodor Escherich 
in 1885.   It is a Gram-negative, non-sporulating, rod-shaped bacterium that belongs to 
the Enterobacteriaceae family of the Gamma Proteobacteria (113).  E. coli is the most 
abundant facultative anaerobe found in the colon of many mammalian species including 
humans, and it constitutes about 1% of human intestinal microbial flora (29).  It was once 
thought that E. coli cells can only survive outside the host environments (e.g. when they 
are periodically deposited into soils and waters) for a limited amount of time, but this 
notion has been increasingly challenged by new research findings (48).  The E. coli 
strains that have been isolated and characterized can be divided into six groups based on 
phylogeny (115).  While the majority of these strains are non-pathogenic, virulent strains 
are responsible for many diseases in humans and other mammals, ranging from diarrhea 
and gastroenteritis to urinary infections and neonatal meningitis (113). 
The complete sequence of the laboratory strain E. coli K12 genome was published 
in 1997.  It is a circular DNA molecule of 4,639,679 bp in length, with a replicative 
origin and terminus about 180º apart.  The entire sequence of E. coli K12 consists of 
4288 annotated protein-encoding genes in 2584 operons, seven ribosomal RNA (rRNA) 
operons, and 86 transfer RNA (tRNA) genes (12).  The genome also contains a large 
number of transposable genetic elements, repeat elements, cryptic prophages, and 
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bacteriophage remnants (113).  In addition to the genome of E. coli K12, the complete 
sequences of over 60 E. coli strains have since been determined, and comparative studies 
revealed a remarkable genetic diversity, with only about 20% of the genome shared by all 
strains (69). 
E. coli cells can grow rapidly and easily under many laboratory conditions.  For 
example, in a rich-nutrient medium such as Luria Broth (LB), they can reach doubling 
times of 20 minutes at 37 ºC (113).  This makes E. coli an ideal model organism in 
microbiology studies. 
1.1.2 Model organism 
E. coli is the best studied cellular form of life and continues to serve as the 
principle model organism in molecular biology.  Experiments on E. coli K12 played a 
central role in our understanding of DNA replication, transcription, translation, gene 
regulation, restriction enzymes and horizontal gene transfer (5, 44).  In addition, E. coli 
was an integral part of the first experiments to study the biology of its bacteriophage 
lambda, which has since expanded into a vast field of its own (23).  Furthermore, E. coli 
also serves as a useful tool to study long-term evolution (63), spatial biophysics of 
adaptation in an island biogeography (57) and even mathematical problems (68).   
Due to its long history of laboratory culture and ease of manipulation, E. coli is 
the most widely used organism in biological engineering: For example, it serves as a 
versatile host for the production of many recombinant proteins, including human insulin 
(122).  Various E. coli-based protein expression systems have also been used in different 
areas such as vaccine development, bioremediation and enzyme immobilization (22). 
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1.2 Bacterial regulatory RNAs 
Historically, RNA is an integral part of the central dogma of DNA  RNA  
Protein that describes how genetic information from DNA directs synthesis of proteins.  
However, it has been established in the past few decades that RNA also plays crucial 
regulatory roles in all three domains of life.  For example, microRNAs are important 
post-transcriptional regulators in many eukaryotes, including humans.  MicroRNAs bind 
complementary sequences on target messenger RNAs (mRNA) and cause gene silencing 
(6).  Furthermore, small interfering RNAs (siRNAs) are a class of double-stranded RNAs 
in eukaryotes that can arise naturally (e.g. from RNA viruses).  After being processed 
eventually into single-stranded molecules as part of RISC complexes, siRNAs can also 
interfere with the expression of target mRNAs with complementary sequences (40).  
The very first bacterial regulatory RNA, RNA I, was discovered in E. coli in 1981 
to inhibit ColE1 plasmid replication by base pairing with the RNA that is otherwise 
cleaved to produce the replication primer (120).  It has since been revealed that bacterial 
cells also possess a vast variety of regulatory RNAs.  These various regulatory RNAs 
play important roles in many physiological processes in bacteria, including transcription, 
translation and mRNA stability (140), and will be further discussed in the following 
sections. 
1.2.1 Base-pairing sRNAs 
Cis-encoded sRNAs 
Cis-encoded sRNAs are commonly transcribed from the DNA strand opposite 
from their target mRNA (hence the name “cis”), but they function in trans as diffusible 
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molecules.  As a result of the gene organization, cis-encoded sRNAs usually share 
extensive complementarity (75 nt or more) with their targets and do not require additional 
proteins to facilitate duplex formation.  They can promote transcription attenuation, 
inhibition of replication primer formation, polycistronic transcript processing, translation 
inhibition and mRNA degradation.  Most cis-encoded sRNAs are expressed from 
bacteriophage, plasmids and transposons to maintain the appropriate copy number of the 
mobile element, but recently a few of them have also been discovered in bacterial 
chromosomes.  The physiological roles of the chromosomal cis-encoded sRNAs are less 
well understood.  However, some function as antitoxins to their toxin target mRNAs, 
while others are involved in stress responses (16, 119, 140).   
Trans-encoded sRNAs 
In contrast to their cis-encoded counterparts, trans-encoded sRNAs are usually 
expressed from chromosomal loci distant from their target mRNAs.  They usually share 
only limited complementarity with these targets.  Because these trans-encoded sRNAs 
only make limited contact with their target mRNAs, they can often base pair with and 
regulate multiple targets.  In addition, they usually require the RNA chaperone Hfq to 
facilitate the duplex formation (140).  The mechanisms by which trans-encoded sRNAs 
regulate their target mRNAs, and the roles of Hfq will be further discussed in 1.2.3 and 
1.2.2, respectively.  
Trans-encoded sRNAs are involved in a wide variety of physiological processes.  
For example, some sRNA regulators (e.g. MicA and OmrB) control the synthesis of 
several outer membrane proteins, thus helping cells cope with envelope stress and 
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osmotic shock (38, 128).  Others play vital roles in modulating metabolism in response to 
environmental changes.  Under iron-limiting conditions, the Fur-regulated RyhB sRNA 
represses expression of many non-essential iron-containing enzymes, thus playing a 
central role in maintaining iron homeostasis (112).  The GcvB sRNA is induced in 
response to high glycine levels and represses several peptide transporters (98-100).  Other 
sRNAs function to modulate synthesis of key transcription factors such as sigma factor 
σS (76) and the quorum sensing regulator LuxR (127).  In addition, sRNA regulators are 
also extensively involved in virulence: For example, the pathogenicity island-encoded 
IsrM sRNA is important for Salmonella invasion of epithelial cells, intracellular 
replication inside macrophages, and colonization in mice (37); the FasX sRNA in group 
A Streptococcus enhances production of a virulence factor, streptokinase (101); and 
several sRNAs in Yersinia pseudotuberculosis are required for virulence (61)  
1.2.2 Proteins involved in sRNA-dependent regulation 
Hfq 
Hfq was initially identified in E. coli as a host factor required for replication of 
the Qβ RNA phage (51).  Subsequent studies have revealed that Hfq is an RNA-binding 
protein that closely resembles many eukaryotic Sm/Sm-like proteins.  In eukaryotes the 
Sm/Sm-like proteins are often involved in mRNA-splicing, RNA chaperoning, and 
stabilization of many RNA species, often through remodeling of RNA secondary 
structures (77).  Similarly in bacteria, Hfq is known for its association with many trans-
encoded sRNAs and its role as a bacterial RNA chaperone in sRNA-dependent post-
transcriptional regulation pathways.  The hexameric ring of Hfq contains a proximal face 
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that recognizes and interacts with single-stranded U-rich sequences (e.g. in sRNA rho-
independent terminator regions), as well as a distal face that binds to single-stranded 
sequences (usually in mRNAs) with an ARN or ARNN motif.  Binding of Hfq often 
results in remodeling the secondary structures of these RNA molecules, which not only 
stabilizes sRNAs but also facilitates their base pairing with target mRNAs (136).  In 
addition, Hfq can promote mRNA turnover either by stimulating polyadenylation at the 3' 
ends of the RNAs (39), which in turn triggers degradation by exoribonuclease (136), or 
by directly recruiting the endoribonuclease RNase E to degrade the sRNA:mRNA 
complex (82).  
A recent report suggested that Hfq is the limiting factor for the function of many 
sRNAs: Different sRNAs compete with different strengths for a limited pool of Hfq 
molecules, which in turn affects levels of sRNA accumulation and target mRNA 
regulation.  The competition can be exacerbated by Hfq becomes further limited (e.g. 
when mutation decreases production of Hfq) and can be overcome by overexpression of 
Hfq (79).  Despite its central roles in sRNA regulation and function, Hfq is not required 
for all trans-encoded sRNAs.  For example, Hfq has been shown to be dispensable for 
sRNA-mediated riboregulation in many low GC Gram-positive species such as 
Staphylococcus aureus and Bacillus subtilis (13, 41).  The Vibrio cholerae sRNA VrrA 
does not require Hfq for its repression of the ompA mRNA, but Hfq binding enhances the 
repression (117).  It remains unclear why Hfq is required in some cases of limited 
complementarity but not others, and possible explanations include more extended base 
pairing or a higher proportion of G:C base pairs, as well as the existence of other yet-to-
be identified RNA chaperones (140).  
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RNase E and the RNA degradosome complex 
RNase E is a single-strand-specific endonuclease that is responsible mainly for 
mRNA degradation, as well as processing of rRNAs and tRNAs.  It preferentially binds 
to AU-rich sequences and initiates mRNA degradation.  RNase E is a large, 1061-amino-
acid protein and an essential enzyme in E. coli, with an N-terminal catalytic domain and a 
C-terminal non-catalytic domain.  The C-terminus of RNase E contains two RNA binding 
sites, as well as three protein-binding sites, one of which is called a scaffold and is 
involved in the assembly of the RNA degradosome complex (18).  The scaffold region is 
also responsible for interaction with Hfq, and this interaction is required for 
sRNA:mRNA degradation (46).  
In addition to RNase E, the RNA degradesome complex also includes PNPase, 
RhlB and enolase.  PNPase (polynucleotide phosphorylase) is a 3' exoribonuclease that 
uses phosphate to cleave phosphodiester bonds.  RhlB is a RNA helicase with a signature 
DEAD-box motif.  Using energy derived from its RNA-dependent ATPase activity, RhlB 
is responsible for unwinding RNA.  Only a small subpopulation of the glycolytic enzyme 
enolase is associated with RNase E as a component of the RNA degradosome.  It has 
been shown to be involved in glucose-phosphate stress response (see 1.4.1) and 
implicated in the degradation of mRNAs encoding enzymes of energy-generating 
pathways.  The non-catalytic C-terminus of RNase E is responsible for direct interaction 
with PNPase, RhlB and enolase respectively.  In the process of mRNA decay, mRNA 
fragments are first generated by the endoribonucleolytic activity of RNase E, and then 
further digested by exoribonucleases such as PNPase, with the help of RhlB and poly (A) 
polymerase (18).   
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1.2.3 Mechanisms of regulation 
Positive regulation  
Among the characterized trans-encoded base pairing sRNAs, there are more that 
repress targets than that activate targets.  The main mechanism of direct activation of 
target mRNA expression by sRNAs is referred to as the anti-antisense mechanism 
(Fig.1.1 A), which is exemplified by the DrsA, RprA and ArcZ sRNAs that positively 
regulate the rpoS mRNA, which encodes the sigma factor σS in E. coli.  Direct binding of 
these sRNAs to the 5' untranslated region (UTR) of the rpoS mRNA prevents formation 
of a secondary stem-loop structure that otherwise sequesters the ribosome-binding site 
(RBS).  Consequently, ribosomes bind the RBS and initiate translation of rpoS (36).   A 
second direct activation mechanism (Fig. 1.1 B) was discovered recently, in which an 
sRNA acts at the level of stabilizing a target mRNA (91).  This mechanism will be 
discussed in detail in 1.4.2.  
Negative regulation 
The most commonly described mechanism of trans-encoded sRNA-mediated 
negative regulation involves the sRNA-mRNA base-pairing that overlaps the mRNA’s 
RBS, thus occluding ribosome binding and inhibiting translation.  Subsequently, the 
endoribonuclease RNase E and the rest of degradosome are recruited to degrade the 
sRNA-mRNA complex (Fig. 1.1 C).  Examples of sRNAs that repress expression of their 
targets via this RBS occlusion mechanism include RyhB, which is responsible for 
translation inhibition and degradation of the sodB mRNA encoding a superoxide 
dismutase (75),  and MicA, which negatively regulates translation and stability of the 
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ompA mRNA encoding a porin protein (102, 128).  However, degradation of the 
sRNA:mRNA complex is not always coupled to translation inhibition.  For example, the 
Spot42 sRNA selectively inhibits translation of galK of the galETK polycistronic 
transcript by the RBS occlusion mechanism, without affecting its mRNA stability (78).  
Furthermore, occlusion of ribosome binding can occur even when the sRNA hybridizes 
with sequences in the 5' coding region of the target mRNA, as in the case of Salmonella 
sRNA RybB and its target ompN.  This presumably acts through steric hindrance: 
RybB:ompN mRNA base pairing blocks entry of the 30s subnit of the ribosome at the 5' 
end of the ompN mRNA, thus inhibiting translation initiation of the latter (14). 
Alternative mechanisms (Fig. 1.1 D) of negative regulation by sRNAs do not 
involve RBS occlusion: For example, Salmonella sRNA MicC base pairs with coding 
sequences (codons 23-26) of the ompD mRNA.  These base pairing interactions lead to 
RNase E-dependent degradation of ompD mRNA directly, without inhibiting its 
translation initiation (92).  On the other hand, Salmonella GcvB sRNA hybridizes with 
the gltI mRNA in a C/A-rich region 57 nt upstream of the start codon.  The C/A-rich 
region may serve as a translational enhancer element, and GcvB pairing with this site, 
therefore, silences the expression of gltI (114). 
1.2.4 Other regulatory RNAs 
Riboswitches 
Riboswitches are RNA elements that undergo structural changes in response to 
the binding of metabolites.  They are encoded within the transcript that they regulate, and 
unlike cis-encoded antisense sRNAs (see 1.2.1), riboswitches act in cis to control the 
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expression of transcript.  The simplest class of riboswitches is the RNA thermosensors 
that are encoded in the 5' UTR of the mRNAs.  They are capable of modulating 
expression of these transcripts in response to a change in temperature.  This is usually 
achieved through RBS sequestration by formation of an inhibitory helical structure, and 
an increase in temperature can melt the RNA helix, releasing RBS so that translation can 
occur (43).  These RNA thermosensors are often used to control expression of heat shock 
genes (80) or to induce virulence-gene expression upon entry into a mammalian host 
(49).  
In contrast to the single-domain RNA thermosensor, a standard riboswitch RNA 
contains a ligand-binding domain (adapter region) as well as a gene expression domain 
(expression platform).  These domains adopt different conformations in the presence or 
absence of the metabolite ligand.  Possible outcomes of riboswitch-mediated regulation 
include disrupting transcription terminators or antiterminators and inhibiting translation 
initiation via RBS occlusion.  Furthermore, the T-box riboswitches are a special class of 
riboswitches that bind specific uncharged tRNAs without the help of any accessory 
factor.  T-box riboswitches control expression of downstream coding sequences, which 
are usually aminoacyl-tRNA synthetase genes and genes involved in amino acid 
biosynthesis and uptake (7, 43).  
sRNAs that modulate protein activity 
 Some protein-binding sRNAs modulate the activity of their cognate proteins by 
mimicking the structures of other nucleic acids.  For instance, 6S RNA, which is 
expressed during stationary phase, mimics the DNA structure of an open promoter and 
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can therefore form a stable complex with σ70-RNA polymerase.  This leads to 
sequestration of the polymerase and consequent inhibition of transcription of numerous 
σ70-dependent promoters during stationary phase.  In addition, 6S RNA also activates 
transcription of several σS-dependent promoters in vivo (139).  The CsrB and CsrC 
sRNAs represent another type of protein-modulating RNA.  They contain multiple 
binding sites recognized by CsrA, an mRNA-binding protein and global regulator of 
carbon metabolism (3).  CsrA most commonly functions as a translational repressor by 
binding the RBS of many transcripts, including the glgC mRNA that encodes glucose-1-
phosphate adenylytransferase involved in glycogen synthese (4) and the sdiA mRNA that 
encodes the N-acylhomoserine-L-lactone receptor (142).  As a result of the CsrB/C 
binding, CsrA is titrated away from the 5' UTR of its intended target mRNAs and 
prevented from serving its role as a translational repressor (3).   
On the other hand, transfer-messenger RNA (tmRNA) represents a different class 
of protein-modulating RNAs.  tmRNA (encoded by ssrA) is a bifunctional RNA with 
both tRNA and mRNA properties, and it plays a vital role in translational surveillance 
and in rescuing stalled ribosomes in a process called trans-translation.  During trans-
translation, tmRNA is delivered to the A site of a stalled translation complex by SmpB 
and EF-Tu, allowing the ribosome to switch templates and resume translation on the 
tmRNA tag reading frame.  Translation terminates at the tag reading frame stop codon, 
and the resulting protein carries a tmRNA-encoded tag that is a target for proteolytic 
degradation.  tmRNA and trans-translation contribute to translational quality control the 
regulation of gene expression, and they are implicated in a wide range of physiological 
processes, including virulence and responses to environmental stresses.  For example, 
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cells deleted for ssrA or smpB have a delayed recovery from stationary phase and are 
more sensitive to amino acid starvation.  The molecular bases for these phenotypes 
remain unknown.  Yersinia pseudotuberculosis strains lacking ssrA or smpB do not cause 
lethality in a mouse infection model and are unable to proliferate in macrophages.  This is 
partially due to misregulation of a transcription factor VirF in the absence of trans-
translation, which results in a delay in the production of a secreted effector protein called 
Yops (55, 56). 
CRISPR 
 The CRISPR (clustered regularly interspaced short palindromic repeats)- Cas 
(CRISPR-associated proteins) system is an RNA-based immune system that was recently 
discovered in bacteria and archaea.  It provides resistance to bacteriophage invasion and 
plasmid conjugation.  CRISPR sequences are characterized by a series of direct, short 
repeats (typically 30-40 nts) that are interspersed with unique spacers of 26 to 72 bps.  
These highly variable spacer sequences bear homology to foreign DNAs of the invading 
bacteriophages and plasmids, and they confer immunity to their corresponding invaders.  
The CRISPR DNA is transcribed into a long RNA, which is subsequently processed by 
the Cascade (CRISPR-Associated Complex for Antiviral Defense) complex of Cas 
proteins into single-stranded repeat-spacer units known as crRNAs.  Directed by the 
Cascade complex and other Cas effector proteins, crRNAs base pair with phage or 
plasmid nucleic acid targets, and silencing can occur at the DNA or RNA level (9, 125, 
140).  In addition to providing resistance to phage and plasmid invasion, the CRISPR-Cas 
system was recently shown to modulate group behaviors such as biofilm formation and 
swarming motility in P. aeruginosa (145).
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1.3 PTS 
The bacterial carbohydrate phosphoenolpyruvate phosphotransferase system	  
(PTS) usually consists of two general cytoplasmic proteins, Enzyme I (EI) and HPr, and a 
sugar-specific Enzyme II (EII) that catalyzes uptake of carbohydrate substrates (Fig.1.2).  
Uptake of carbohydrates through the PTS, which is referred to as group translocation, is 
coupled to a series of phosphorylation events; as a result, phosphorylated sugar 
derivatives accumulate inside the cells.  The ultimate energy source and phosphoryl 
donor of PTS is phosphoenolpyruvate (PEP) (96). 
Encoded by the ptsI gene, EI accepts a phosphoryl group from PEP and as a result 
is phosphorylated on a histidine residue (His189) in its N-terminal domain.  The 
phosphorylation requires both the homodimeric form of EI and the presence of Mg2+ ion 
(19).  The phosphoryl group is then transferred from phosphorylated EI to the other 
sugar-non-specific constituent of the PTS, a monomeric, single domain protein called 
HPr (encoded by ptsH) (26, 96). 
The carbohydrate-specific EII complex is the next recipient of the phosphoryl 
group from HPr.  EIIs can be a single membrane-bound protein with three domains, or up 
to four separate proteins (at least one of which is membrane-bound).  They are 
responsible for donating phosphates to carbohydrate substrates (26).  E. coli K12 
possesses four superfamilies of different EII complexes,  and two of these complexes will 
be discussed in the following sections.  
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1.3.1 Crr (EIIAGlc) and PtsG (EIICBGlc) 
The glucose-specific permease EIIGlc complex consists of the cytoplasmic Crr 
(EIIAGlc) and the membrane-associated PtsG (EIICBGlc).  The IIB domain of PtsG extends 
into the cytoplasm, whereas the IIC domain contains eight transmembrane α-helical 
segments (17).  The EIIGlc complex mediates transport of glucose, a glucose analog α-
methyl-glucoside  (αMG) and, to a lesser extent, mannose and another glucose analog, 2-
deoxyglucose (2DG) (42).  
Crr plays a central role in carbon catabolite repression in E. coli: Phosphorylated 
Crr stimulates the activity of adenylate cyclase, the enzyme responsible for the synthesis 
of cAMP, which together with CRP regulates transcription of many genes encoding 
catabolic enzymes.  During glucose uptake by PTS, Crr exists mainly in the 
dephosphorylated form, which cannot stimulate adenylate cyclase, and as a result, 
transcription of many cAMP-dependent genes is inhibited.  Nonetheless, there is always a 
basal level of cAMP synthesized, regardless of the carbon source, to activate transcription 
of genes for PTS sugar metabolism.  In addition, dephosphorylated Crr can directly bind 
to and inhibit many proteins that are essential for the transport (e.g., the lactose and 
melibiose transporters) or catabolism (e.g., glycerol kinase) of non-PTS substrates.  This 
effect is referred to as inducer exclusion.  As a result, when E. coli cells are presented 
with a choice of glucose and another carbon source, they will preferentially utilize 
glucose until its depletion and only then begin to utilize the second carbon source.  This 
phenomenon is known as diauxic growth (26). 
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1.3.2 ManXYZ (EIIABMan, EIICDMan) 
The mannose-specific PTS permease EIIMan complex possesses four domains in 
three polypeptides: The IIA and IIB domains constitute a single cytoplasmic protein 
encoded by the manX gene, whereas the IIC and IID domains are membrane-bound 
proteins encoded by the manY and manZ genes respectively.  manXYZ  is encoded in an 
operon.  In addition to mannose, ManXYZ has been shown to transport glucose, 
glucosamine, fructose, 2DG, mannosamine, N-acetylglucosamine and αMG (96).   
Interestingly, ManY and ManZ also function as host factors to allow infection of 
E. coli by λ phage, whereas ManX is not required (33).  Other reports showed that 
ManYZ is strictly required for bactericidal activities of microcin E492 (MccE492) and 
lactococcin A toxins that are secreted by Klebsiella pneumoniae and Lactococcus lactis, 
respectively, against various Enterobacteriaceae, including E. coli (10, 11, 60). 
1.3.3 Transcriptional regulation of the PTS 
The expression of the PTS genes is subjected to complex regulations.  The ptsI, 
ptsH and crr genes form an operon with at least two promoters upstream of ptsH plus an 
internal promoter for crr located within the ptsI gene.  The upstream ptsHIcrr promoter 
(p0) is induced by glucose and requires the cyclic AMP (cAMP)-receptor protein (CRP) 
complex (24) and repressed by the transcription regulator Mlc (95).  In contrast, the 
expression of crr from its own promoter is constitutive in E. coli K12 (24).  On the other 
hand, transcription of ptsG, which is not associated with the ptsHIcrr operon, is 
positively regulated by the cAMP-CRP complex (26) and negatively regulated by Mlc 
(124).  In the presence of glucose, dephosphorylated IIB domain of PtsG sequesters Mlc 
to the membrane, consequently disabling the repressor function of Mlc (85).  Similar to 
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ptsG, transcription of manXYZ is subjected to activation by the cAMP-CRP complex and 
repression by Mlc (94). 
1.4 The sugar-phosphate stress response 
The toxicity associated with accumulation of sugar-phosphates has been well 
documented since the 1950s (143).  Sugar-phosphates accumulate when mutations in 
certain metabolic enzymes obstruct metabolic flux or when cells import non-
metabolizable sugar analogs.  The results are often growth inhibitory or even bactericidal.  
In most cases, molecular mechanisms underlying the toxicity remain to be elucidated (32, 
47, 50, 64). 
1.4.1 Glucose-phosphate (GP) stress 
GP stress (Fig.1.2) was first described by Kimata et. al. in their search for 
mutations that would allow expression of the lac operon in the presence of glucose.  They 
demonstrated that in E. coli cells harboring a mutation in either the pgi or pfkA genes, 
which encode phosphoglucose isomerase (Pgi) or phosphofructokinase (Pfk), 
respectively, suppression of the lac operon by glucose was eliminated.  They further 
determined that these mutations reduced expression of the glucose transporter gene ptsG 
(see 1.3.2) by accelerating the degradation of ptsG mRNA.  The effect could be reversed 
by feeding cells with glycolytic intermediates downstream of the block in glycolysis 
created by these mutations, as well as by inactivating RNase E (59).  Cells lacking Pgi, 
which is responsible for converting G6P to fructose-6-phosphate, experience transient 
growth inhibition following exposure to glucose, and this phenomenon has thereafter 
been referred to as GP stress (or phosphosugar stress; the terms are often used 
interchangeably).  A subsequent report suggested that accumulation of G6P is the source 
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of the stress, because overexpression of the zwf gene encoding G6P dehydrogenase that 
funnels G6P into the pentose phosphate pathway, could effectively alleviate the stress 
and eliminate degradation of ptsG mRNA (81).  
Kimata et. al also reported that exposure of the wild type cells to the glucose 
analog α-methyl glucoside (αMG), which cannot be metabolized further by E. coli once 
transported into cells (mostly by PtsG), could also induce GP stress and the 
destabilization of ptsG mRNA (59).  Recently, it was demonstrated in our laboratory that 
another non-metabolizable glucose analog, 2-deoxy-glucose (2DG), which is mainly 
taken up by ManXYZ, also causes GP stress in wild type E. coli cells (106).  
The exact nature of GP stress, as well as the mechanism underlying the observed 
growth inhibition, remains unknown.  It is also unclear when E. coli cells experience this 
stress under natural circumstances.  Some enteric species such as Klebsiella pneumoniae 
are equipped with enzymes to metabolize αMG (93); some fungi, as well as some 
Pseudomonadaceae species, can utilize 2DG as a carbon source (30).  These reports raise 
the possibility that these stress-causing compounds may be encountered by and 
accidentally transported into E. coli cells in nature.  Furthermore, the initial Kimata study 
also reported that utilization of amino acids as the sole carbon source could partially 
stimulate, in wild type E. coli cells, the degradation of ptsG mRNA, which is often 
indicative of GP stress (59).  Athough several mysteries regarding the physiological 
signals and consequences of GP stress remain, in 2004, Vanderpool and Gottesman 
uncovered a small RNA involved in regulating the GP stress response (132). 
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1.4.2 SgrS 
Overview	  
 The trans-encoded sRNA SgrS was first discovered in a microarray analysis of 
RNA molecules that were co-immunoprecipitated with Hfq (146).  It is 227 bp in length 
and located in the sgrR-setA intergenic region at ~1.65 min on the E. coli K12 
chromosome.  The 3' region of SgrS contains conserved sequences that are critical for its 
base pairing function, as well as a Rho-independent terminator and polyU tail that serve 
as a binding site for the RNA chaperone Hfq (88).  Furthermore, the 5' region of SgrS 
encodes a 43 amino acid protein called SgrT (See 1.4.4). 
A transcriptional activator called SgrR (see 1.4.3) induces expression of SgrS 
under GP stress conditions.  Cells that lack SgrS are defective for growth with αMG.  
This defect can be alleviated by ectopical expression of SgrS from a plasmid, suggesting 
that SgrS is required for a cellular response to GP stress.  In addition, the growth of cells 
that overexpress SgrS is severely inhibited on glucose and mannose, which is indicative 
of the involvement of SgrS in sugar uptake or metabolism (132).  The mechanisms 
underlying the above-described growth phenotypes that are associated with SgrS will be 
further discussed in the following section.  
Regulation of multiple targets 
ptsG 
When expressed under GP stress, SgrS base pairs with the ptsG mRNA (Fig.1.3), 
which encodes the major PTS transporter protein responsible for glucose and αMG 
uptake (132).  The RNA chaperone Hfq stabilizes SgrS and facilitates the base pairing 
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interaction between conserved sequences in the SgrS 3' end and the Shine-Dalgarno 
region of ptsG mRNA.  This binding results in translation inhibition of the latter (53, 71, 
72).  With the help of Hfq, SgrS:ptsG mRNA base pairing also recruits the RNase E 
degradosome complex (see 1.2), leading to degradation of the sRNA-mRNA complex 
(53, 129, 132).  It has been demonstrated that translation inhibition is sufficient to silence 
ptsG expression even in the absence of mRNA degradation (83).  Down-regulation of 
PtsG production by SgrS helps cells recover from growth inhibition by αMG, presumably 
because it reduces cellular uptake of the stress-causing molecules (109, 130, 132). 
Six nucleotides in the Shine-Dalgarno region of ptsG mRNA are of particular 
importance to the duplex formation (53, 129).  However, only two bases in the central 
SgrS:ptsG interaction were shown to be absolutely required for the translational 
repression of ptsG and recovery from αMG-induced GP stress (138).  Furthermore, 
localization of the ptsG mRNA to the inner membrane, as well as membrane insertion of 
the nascent PtsG peptide, are also important for the action of SgrS (54). 
manXYZ 
Our laboratory has recently reported SgrS-mediated negative regulation of a 
second mRNA target: the manXYZ polycistronic transcript (Fig. 1.3), which encodes a 
PTS transporter responsible for uptake of mannose and, to a lesser extent, glucose.  A 
ptsG deletion mutant strain that is manXYZ+ experiences GP stress when exposed to αMG 
or 2DG, whereas a ptsG manXYZ double mutant is resistant to the stress, suggesting that 
in addition to PtsG, ManXYZ is also involved in taking up of the stress-causing 
substrates (106). 
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SgrS base pairs with sequences within the manX coding region and inhibits its 
translation.  Regulation of manX does not require the RNase E degradosome complex, 
suggesting that the primary mechanism of regulation is translational silencing (106).  
Furthermore, SgrS also base pairs with sequences in the manX-manY intergenic region 
and represses translation of manY and manZ through a mechanism that is independent of 
base pairing with manX.  Base pairing interactions at both sites are required for the SgrS-
dependent manXYZ mRNA degradation, as well as the maximal recovery from GP stress 
(105). 
yigL 
We recently collaborated with Dr. Jörg Vogel’s laboratory at the University of 
Würzburg, Germany, to report SgrS-dependent activation of yigL (Fig. 1.3, (91)).  YigL 
is a phosphatase that belongs to the superfamily of haloacid dehalogenase-like hydrolases 
(123).  Previous in vitro experiments demonstrated that YigL is capable of 
dephosphorylating numerous sugar phosphates, including G6P, 2DG-phosphate and 
αMG-phosphate (62).  
yigL is co-transcribed with an upstream gene, pldB, which encodes 
lysophospholipase L2 (52).  The bicistronic transcript subsequently undergoes RNase E-
dependent cleavage at a site within the coding region of pldB, ~200 nt upstream of the 
yigL start codon.  SgrS base pairs with the processed yigL transcript.  Instead of 
influencing target translation initiation, SgrS promotes YigL production exclusively 
through direct stabilization of the yigL mRNA (91).
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 Cells that lack YigL are severely defective for growth under certain GP stress-
inducing conditions, and YigL in trans eliminates the defect, suggesting that YigL is 
required for recovery from GP stress.  Northern analysis showed that a yigL deletion did 
not affect induction rate of SgrS following exposure of the cells to αMG, but it resulted 
in steadily high levels of SgrS even after removal of αMG, indicating the chronic nature 
of GP stress in the absence of YigL.  YigL is suggested to dephosphorylate αMG-
phosphate, which can then be pumped out the cells (91).  This is consistent with a 
previous report of αMG dephosphorylation as a prerequisite for secretion (141).  
1.4.3 SgrR 
SgrR is a transcription factor required for αMG-responsive induction of sgrS 
expression and recovery from GP stress.  The sgrR gene is located upstream of sgrS and 
is divergently transcribed (Fig. 1.3).  This gene organization is conserved among 
numerous enteric species (45).  Under GP stress conditions, cells that lack SgrR are 
strongly inhibited, and SgrS in trans can eliminate the defect, suggesting that inducing 
transcription of SgrS is a primary function of SgrR in response to stress.  On the other 
hand, ectopic expression of SgrR from a plasmid does not induce sgrS unless GP stress is 
induced, which strongly suggests that a stress signal serves as co-activator for SgrR in 
promoting sgrS transcription (132).      
The SgrR protein (551 amino acid in length with a molecular mass of 64 kDa) 
represents a novel family of bacterial transcription factors that contain an N-terminal 
DNA binding domain and a C-terminal solute domain.  SgrR specifically binds to a site 
in the sgrR-sgrS intergenic region to activate sgrS expression under GP stress.  The C-
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terminal solute-binding domain of SgrR is also required for GP stress responsive 
induction of sgrS, which is consistent with the model that SgrR is responsible for 
recognizing and binding of the stress signal.  In addition, SgrR negatively autoregulates 
its own transcription independently of the stress, and the autorepression requires the same 
binding site in the sgrR-sgrS intergenic region (133).   
1.4.4 SgrT 
The 5' end of sgrS, upstream of the region involved in base pairing with target 
mRNAs, encodes a 43-amino-acid protein called SgrT (Fig.1.3).  Plasmid-born copies of 
SgrT rescue the ΔsgrS mutant cells from growth inhibition under GP stress conditions, 
via a mechanism that is independent from the base pairing function of SgrS: SgrT has no 
effect on the stability or translation of the ptsG mRNA.  Cells overexpressing SgrT 
exhibit a defect in glucose uptake, which supports the notion that SgrT may act at the 
level of PtsG activity (131, 138).  SgrT is poorly expressed from its native promoter in E. 
coli K12, due to the presence of a putative secondary structure in the SgrS 5' region that 
occludes the ribosome-binding site.  This inhibitory secondary structure is absent in 
Salmonella typhimurium SgrS, which results in higher-level SgrT production in this 
organism than in E. coli K12 (137). 
1.4.5 PitA 
Our laboratory recently reported that deletion of the pitA gene, which encodes the 
low-affinity transporter of inorganic phosphate, partially suppressed the growth defect of 
an sgrS mutant under αMG-induced GP stress conditions (Fig. 1.3).  In addition, the pitA 
mutation also reduced the induction of sgrS transcription in response to the stress.  It was 
demonstrated that the deletion of pitA in the sgrS mutant background results in a slight 
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increase in the PtsG transporter activity.  Furthermore, mutation of pitA leads to induction 
of the phosphate starvation (Pho) regulon, which partially suppresses the growth defect of 
the sgrS mutant under GP stress.  On the other hand, deletion of 24 individual Pho 
regulon genes in the pitA sgrS background showed that none of them individually is 
responsible for the observed suppression phenotype.  This study was the first to suggest a 
novel link between carbon and phosphate metabolism (108).   
1.4.6 Regulation of sugar transporters by sRNAs in pathogens 
The TarA sRNA of V. cholerae was recently shown to negatively regulate the 
ptsG mRNA.  TarA, whose expression is activated by the virulence transcription activator 
ToxT, shares no similarity with SgrS of E. coli and does not encode any peptide.  An 
analysis using a base pairing prediction program indicated potential interactions between 
TarA and the 5' UTR of the ptsG mRNA, which is the same region that interacts with 
SgrS and overlaps the RBS of ptsG in E. coli.  Deletion of Hfq reduced TarA levels, 
suggesting that Hfq might be involved in stabilization of TarA sRNA.  A V. cholerae 
mutant lacking TarA was deficient in infant mouse colonization compared to the wild 
type strain, suggesting that TarA, and potentially ptsG, is involved in the in vivo fitness of 
V. cholerae (107). 
Recently, Bowden et. al. reported that glucose transport through PtsG or 
ManXYZ is required for replication of S. typhimurium within macrophages, as mutants 
lacking ptsG or manXYZ showed reduced replication (15).  It remains unclear whether 
SgrS (which has a functional homolog in S. typhimurium) plays any significant role in 
that scenario.  Interestingly, a separate study showed that SgrS base pairs with and 
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regulates the S. typhimurium-specific sopD mRNA, which encodes a secreted virulence 
protein, linking SgrS with pathogenesis of this organism (90). 
1.5 Major Facilitator Superfamily (MFS) transporters 
The MFS is a large group of membrane transporters that includes over 10,000 
members in bacteria, archaea and eukarya.  They usually possess 12, 14 or 24 putative 
transmembrane spanning domains and can catalyze uniport, solute:cation symport, and 
solute:H+ or solute: solute antiport.  MFS members can transport a great variety of 
substrates, ranging from sugars, amino acids and siderophores to antibiotics, TCA cycle 
metabolites and neurotransmitters (34, 89). 
1.5.1 Sugar Efflux Transporter (SET) family  
The SET family of efflux pumps includes three members (SetA, SetB and SetC) 
in E. coli K12 (67) and a fourth member, SotA, in Dickeya dadantii (formerly known as 
Erwinia chrysanthemi) (21, 89, 111).  SetA, SetB and SetC share at least 70% amino acid 
sequence similarity with each other.  In addition, they also share a high degree of amino 
acid sequence similarity with other MFS proteins, including a degenerate signature motif 
[GX3(D/E)(R/K)XG[X](R/K)(R/K)] (66).   
SetA will be further discussed in 1.5.2.  An in vitro study of SET family members 
in E. coli K12 demonstrated that SetB can transport both lactose and glucose (66, 67).  
Cells overexpressing SetB are desensitized to the lactose analog, isopropyl-β-D-
thiogalactopyranoside (IPTG), as measured by induction of the lac operon (67).  On the 
other hand, the substrates of SetC remain unknown: The same study stated that in vitro, 
cells with setC expression constructs did not transport glucose, galactose or lactose (67).  
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Expression of D. dadantii SotA can also prevent intracellular accumulation of IPTG, 
lactose and arabinose, and it can reduce IPTG induction of the lac promoter in E. coli 
(21). 
1.5.2 SetA 
Discovery 
 SetA was first discovered by Liu et. al. in E. coli (66).  They observed that 
overexpression of AcrB from an IPTG-inducible promoter on a plasmid inhibits growth 
in E. coli.  AcrB functions as a part of AcrAB/TolC multidrug-efflux complex (86).  SetA 
was identified as a multi-copy suppressor of the above-described toxicity, and the 
suppression was due to SetA pumping IPTG out of the cell (66).   
Overview 
SetA (392 amino acid in length and 42.7 kDa) is a member of the SET family 
(67).  An in vitro study of SetA revealed that it is a proton motive force-driven antiporter 
capable of transporting a wide range of substrates, with preferences for glucosides or 
galactosides with alkyl or aryl substitutents.  Glucose, lactose, IPTG and αMG, but not 
any negatively charged compounds, were among the demonstrated in vitro substrates that 
can be transported by SetA.  Cells that overexpress SetA are desensitized to IPTG and 
resistant to growth inhibition caused by a toxic sugar analog o-nitrophenyl-β−galactoside 
(ONPG) (67).    
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Gene organization with sgrS and sgrR	  
The 1179 nt-long setA gene is located downstream of sgrS (see 1.5.2) and sgrR 
(see 1.5.3) on the E. coli K12 genome.  The gene organization of sgrR, sgrS and setA is 
conserved among many enteric species (Fig. 1.3), including Shigella flexneri, Klebsiella 
pnemoniae and Yersinia pestis (45, 121).  This prompted our speculation that SetA might 
play a role in the glucose-phosphate stress response.  The short intergenic region between 
sgrS and setA (27 nt in the E. coli K12 genome) also suggested the possibility that the 
two genes might form an operon.  
1.6 Aim of this study 
Increasing numbers of sRNAs, including SgrS, have been shown to regulate 
multiple targets.  Most studies so far have been focused on the molecular mechanisms of 
individual target regulation by SgrS.  However, at the time when we initiated our studies, 
it remained largely unclear how coordinated regulation of these multiple targets 
contributes to the GP stress response.  The aim of this study was to investigate how SgrS 
regulation of different targets impacts growth in response to different inducers of GP 
stress (αMG or 2DG), in varying nutrient environments. We hypothesized that regulation 
of some targets would be more important than others in terms of rescuing cell growth 
during stress, and this arrangement might change to match fluctuations in the 
environment.  
In addition, we also sought to define the regulation and physiological function of 
SetA in the GP stress response.  Based on the conserved genomic organization between 
sgrR, sgrS and setA, as well as the in vitro information regarding the biochemistry of 
SetA protein, we speculated that SetA might play a role in cellular recovery from GP 
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stress.  We further wanted to investigate whether SetA was responsible for directly 
transporting the dephosphorylated forms of stress-causing molecules out of the cells. 
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1.7 Figures 
 
Fig. 1.1 Mechanisms of target regulation by trans-encoded base-pairing sRNAs.  
Trans-encoded sRNAs can positively regulate their targets by either A. preventing the 
formation of an inhibitory structure which otherwise causes ribosome occlusion, or B. 
protecting the target from degradation by nuclease.  C. These sRNAs can also act 
negatively by base pairing with the 5ʹ′ UTR to sequester the RBS, which results in 
translation inhibition and/or sRNA:mRNA duplex degradation. D. Alternatively, the base 
pairing interaction can block binding of translational enhancers. 
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Fig. 1.2 PTS and glucose phosphate stress. The bacterial carbohydrate PTS consists of two 
general cytoplasmic proteins, EI and HPr, and sugar-specific EII.  Only the glucose-specific 
and mannose-specific EII complexes are depicted here.  Intracellular accumulation of 
phosphorylated forms of non-metabolizable glucose analogs αMG (transported mainly by 
glucose-specific PTS transporter) or 2DG (transported mainly by mannose-specific PTS 
transporter) causes growth inhibition in E. coli K12.  This phenomenon is referred to as 
glucose phosphate (GP) stress. 
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Fig. 1.3 Model for the SgrS-mediated GP stress response.  Under GP stress, SgrR 
activates transcription of sgrS.  SgrS associates with Hfq and regulates its target mRNAs, 
which in turn helps cellular recovery from GP stress.  The three confirmed targets — 
ptsG, manXYZ and yigL — are depicted here.  sgrS also encodes a small peptide SgrT, 
which inhibits glucose uptake.  The setA gene located downstream of sgrS on the 
chromosome encodes a sugar efflux transporter. 
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CHAPTER 2:  MATERIALS AND METHODS 
2.1 Strains and plasmid construction 
Most strains used for this study are derivatives of DJ480 (D. Jin, National Cancer 
Institute) and are listed in Table 2.1.  The sequences of all oligonucleotides (Integrated 
DNA Technologies) used in the construction of mutant strains and plasmids are listed in 
Table 2.2. 
2.1.1 Reporter fusion construction 
The sgrS′-lacZ transcriptional reporter fusion was constructed by B. Hussain in 
our laboratory via previously described methods (132).  Briefly, the sgrS promoter 
fragment was amplified by primers O-BAH102 and O-CV142 (Table 2.2) containing 
EcoRI or BamHI sites, respectively, and cloned into plasmid pRS1553.  The fusion was 
crossed into the λattB site on the host chromosome (132), resulting in BAH100.  The 
setA′-lacZ transcriptional fusion in YS131 was constructed using the λ-Red and FLP-
mediated site-specific recombination method described previously (31).  Briefly, a 
kanamycin cassette flanked by FLP recombination target (FRT) sites was amplified from 
template pKD13 (31) using primers O-YS125 and O-YS126 (Table 2.2) and integrated 
into the chromosome by λ-Red recombination at the setA locus. The remaining steps were 
as described in reference 31. 
Strains JH116 and JH171, which contain the manXʹ′-ʹ′lacZ and ptsGʹ′-ʹ′lacZ 
translational fusions respectively, were described in a previous study (106).  The yigLʹ′-
ʹ′lacZ translational fusion was created using a technique described previously (31).  
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Briefly, a kanamycin cassette flanked by a FLP recombination target (FRT) site was 
amplified from template pKD13 using oligonucleotides O-YS206 and O-YS207 (Table 
2.2) and integrated into the chromosome by λ-Red recombination at the yigL locus.  The 
kanamycin cassette was then removed using the helper plasmid pCP20 encoding the FLP 
recombinase, resulting in a strain carrying a single FRT site.  Subsequently, translational 
fusion vector pCE40 (31) was integrated into the chromosome by FLP-dependent site-
specific recombination, resulting in ʹ′lacZ  fused to the 17th codon of yigL and linked to 
the kanamycin cassette.  The fusion was then transduced by P1 phage into a previously 
described strain, JH111  (which is lacIq+ and ΔsgrS, Table 2.2) to create YS234. 
2.1.2 Mutant construction 
BAH101 was created by B. Hussain (in our laboratory) by moving a ΔsgrR::cm 
allele into the BAH100 host via P1 transduction.  CS168 was created by C. S. Wadler in 
our laboratory by P1 transduction of λattB::lacIq Spr tetR from donor DH5αZ1 (70) into 
recipient DJ480.  The ΔsetA::cm deletion-insertion mutation in ST101 was constructed 
by S. Tsang in our laboratory using the λ-Red recombination system (144) and primers 
O-CV170 and O-CV171 (Table 2.2).  YS133 is derived from YS131 and contains a 
ΔsgrR::cm allele that was constructed by homologous recombination (144) with a PCR 
product obtained using primers ΔyabNcm1 and ΔyabNcm2 (Table 2.2).  To construct 
YS135, a single-stranded oligonucleotide, O-YS135 (Table 2.2), was transformed into 
CV1300 to replace the cat-sacB cassette carried by the latter in the SgrR-binding site.  
The setAʹ′-lacZ fusion was then introduced into YS135 by the same method used for 
YS131 construction, resulting in strain YS140.  YS137 was derived from CS100 (137) by 
looping out the cat-sacB cassette in the −10 region of the sgrS promoter using the 
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oligonucleotide O-YS134 (Table 2.2).  YS142 was subsequently made by constructing 
the setAʹ′-lacZ fusion in the YS137 background.  YS143 was created by moving the 
ΔsetA::cm allele into CS168 via P1 transduction.  YS144 is derived from CS123, which 
contains the sgrS1 mutation (137), and was constructed by transducing the λattB::lacIq 
Spr tetR allele into CS123.  YS214 was created by transducing the ΔsetA::cm allele into 
BAH100.  YS215 is derived from CS104 (137), which contains a ΔsgrS allele, and was 
constructed by inserting the sgrSʹ′-lacZ transcriptional fusion in single copy into the λattB 
site as described previously (132).  YS219 was made first by P1 transduction of a 
ΔkdgR::FRT-kan-FRT allele from donor JW1816 (2) to recipient DJ480; the kanamycin 
cassette was then removed by a previously described method (31), and the setAʹ′-lacZ 
fusion was moved in by P1 transduction.  YS224 is derived from CS123 and was created 
by inserting the sgrSʹ′-lacZ transcriptional fusion in single copy into the λattB sites of the 
respective strains as described previously (132).  Using the same method, the sgrSʹ′-lacZ 
fusion was inserted into YS219, resulting in strain YS225.  YS228 was constructed by 
moving a Δcrp::cm allele into BAH100 through P1 transduction.  YS231 was created by 
moving a Δcrp::cm allele to YS131 by P1 transduction. 
Strains CS104 and CS123, which carry the ΔsgrS and sgrS1 mutations 
respectively, were described previously (137).  The ΔmanXYZ::kan allele was moved into 
strain CS104 via P1 transduction to create strain CS184 by C. Wadler in our laboratory.  
The ΔptsG::cm allele was transduced into strain CS104 to create strain CV106.  
Chromosomal sgrS26 and sgrS28 alleles were constructed using a strategy modified from 
the one described in a previous study (65) and a strain that carries the kanamycin cassette 
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fused to the araC gene and the toxin gene ccdB under control of the PBAD promoter (a gift 
from N. Majdalani, National Cancer Institute).  The kan-araC-PBAD-ccdB region was PCR 
amplified by oligonucleotides O-YS226/O-YS227 and inserted into the sgrS locus of 
NM300 (which carries a mini-λ encoding λ Red functions (23, 132, 144)), resulting in 
YS246.  Mini-λ was maintained in YS246 by growth at 30°C.  Subsequently, the sgrS26 
allele was PCR amplified from plasmid pBRJH26, using oligonucleotides O-YS261 and 
O-YS230.  The sgrS28 allele was amplified using genomic DNA of wild-type DJ480 as 
the template, and oligonucleotides O-YS228/O-YS230, which incorporated the desired 
point mutations.  Following induction of λ Red functions in strain YS246, sgrS26 and 
sgrS28 PCR products were transformed by electroporation, yielding strains YS269 and 
YS248, respectively.  Recombinants were obtained by counter-selection against ccdB by 
plating cells on media containing 1% L-arabinose.   
To create the ΔyigL::FRT-kan-FRT allele, a kanamycin cassette flanked by FLP 
recombination target (FRT) sites was amplified from template pKD13 (31) using 
oligonucletotides O-YS156/O-YS157.  The ΔyigL::FRT-kan-FRT allele was then moved 
into CS168 and the previously described JH111 (106) by P1 transduction.  Subsequently, 
the kanamycin-resistance cassettes in these were eliminated using a plasmid pCP20 that 
expresses FLP recombinase (31); the resulting strains are YS184, CS194 and CS195.   
The attB::tet allele in strain YS236 was created using primers O-YS213/O-
YS214, with homology to the attB locus to amplify the tetracycline resistance cassette, 
followed by λ Red recombination (144).  This mutant allele was then transduced into 
strains DJ480, CV106, CS104, CS123, CS184, YS185, YS208, YS248 and YS269 to 
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yield YS237, YS284, YS247, YS238, YS83, YS273, YS285, YS249 and YS270, 
respectively.   The ΔptsG::cm allele was moved into YS237 by P1 transduction to result 
in strain YS286. 
To insert the Plac promoter on the chromosome upstream of ptsG, we first 
amplified a chloramphenicol cassette from strain CV700, using oligonucleotides O-
YS225 and O-YS238 that contain sequences homologous to the cat gene and the Plac 
promoter.  The resulting PCR product, which has the chloramphenicol cassette linked to 
the Plac promoter, then served as the template for the next round of PCR amplification.  
Using oligonucleotides O-YS240 and O-YS241, we obtained a new PCR product, which 
contains the cat gene-linked Plac promoter that is flanked by the -177 to -140 region 
relative to the ptsG start codon, as well as the first 30nt of ptsG coding sequence.  Using 
this PCR product and the λ-Red recombination system (144), we created the cm-Plac-ptsG 
allele, which was then transduced into JH111, CS168 and CS195, resulting in strains 
YS258, YS259 and YS265. 
2.1.3 Plasmid construction 
DH5α (Invitrogen) was used for routine cloning procedures.  Plasmid pZE21 was 
described in a previous study (70) and was kindly provided by J. Cronan.  To construct 
plasmid pZEYS1, the setA gene was amplified by PCR using primer pairs O-YS130 and 
O-CV193 (Table 2.2), which contain BamHI and KpnI sites, and subsequently cloned 
into the BamHI- and KpnI-cut vector pZE21.  To construct plasmid pZEYS2, the yigL 
gene was amplified by PCR using the forward primer O-YS215, which contains a HindIII 
site and a 24 nt fragment from the pQE80L vector (QIAGEN) carrying the ribosome 
binding site, followed by yigL sequence.  The reverse primer, O-YS216, contains a 
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BamHI site and sequences homologous to the region downstream of the predicted yigL 
terminator.  The HindIII and BamHI-digested PCR product was then cloned into pZE21, 
resulting in pZEYS2. 
XL10 (Stratagene) was used for QuikChange Mutagenesis.  Plasmid pLCV1, 
pBRCS6 and pBRJH26 that carry wild-type sgrS, sgrS1 and sgrS26, respectively were 
described in previous studies (106, 137).  Plasmid pBRYS4, containing the sgrS28 allele, 
was created using the QuikChange II Site-Directed Mutagenesis kit (Agilent 
Technologies) with oligonucleotide O-YS212 and the previously-described plasmid 
pBRJH19 (106) as template. 
Plasmid pBRBAH3 was created by B. Hussain in our laboratory using the XL1-
Red system (Stratagene).  Briefly, plasmid pLCV3 carrying the wild-type sgrR gene 
(132) was transformed into the E. coli mutator strain XL1-Red, and the transformants 
were grown over many generations using serial passages.  Pools of mutagenized plasmids 
generated by this method were then transformed into host strain CV5230, which contains 
an sgrS′-lacZ fusion and a ΔsgrR mutation on the chromosome (132).  The transformants 
were screened on lactose MacConkey indicator plates for the Lac+ phenotype, and 
plasmid pBRBAH3 obtained from the screening was then sequenced to identify the 
locations of mutations in sgrR. 
2.2  β-galactosidase assays 
2.2.1 Transcriptional fusions 
Strains were grown overnight in LB (100 μg/ml ampicillin was added to the 
medium when working with strains carrying plasmids pHDB3 and pBRBAH3) or 
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minimal MOPS (morpholinepropanesulfonic acid) medium (Teknova) supplemented with 
0.4% glycerol or 0.2% fructose and subcultured 1:200 in fresh medium.  The cultures 
were grown to an optical density at 600 nm (OD600) of ∼0.5 and split into two separate 
cultures.  αMG (Sigma) was added to one of the cultures to the indicated final 
concentrations.  For testing differences in growth under stress conditions, αMG was used 
at a final concentration of 0.5%.  We had shown previously that wild-type and ΔsgrS 
strains have distinctly different growth characteristics at this αMG concentration (137, 
138).  For experiments testing signaling leading to transcriptional activation of sgrS′-
lacZ, a lower concentration of αMG was used (0.001%) because the sgrS promoter is 
very sensitive to induction under stress conditions and higher concentrations saturate the 
activation.  For testing signaling through activation of setAʹ′-lacZ, a final concentration of 
0.1% αMG was used because this fusion is less sensitive to induction than the sgrSʹ′-lacZ 
fusion. Samples were taken 45 min after the addition of αMG to the appropriate cultures 
and assayed for β-galactosidase activity as described previously (20). 
2.2.2 Translational fusions 
Strains containing translational fusions were grown overnight in TB medium with 
100µg/ml ampicillin and subcultured 1:200 to fresh medium.  Cultures were grown to an 
OD600 ~0.5 and exposed to 0.1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG).  
Samples were taken one hour later and assayed for β-galactosidase activity as described 
previously.  The activity (measured in Miller Units) produced by cells carrying the vector 
control was set to 1.0.  Activity values for other strains were normalized to the vector 
control to give relative activity for experimental samples (20). 
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2.3 RNA extraction and northern blot analyses 
To examine stabilities of SgrS variants, strains were grown in LB medium to 
OD600 ~0.5 and exposed to 0.5% αMG (Sigma) for 10 minutes.  250 µg/ml rifampicin 
was then added to the cultures and RNA was extracted at the indicated time intervals by 
the previously-described hot phenol method (132).  Northern blot analysis with probe 
sgrS-1bio (132)	  was used to detect the SgrS RNA.	  
2.4 Growth experiments 
For growth competition experiments, cells were grown overnight in LB or 
minimal MOPS (morpholinepropanesulfonic acid) medium (Teknova) supplemented with 
0.4% glycerol or 0.2% fructose as indicated.  Two competing strains were mixed at 1:1 
ratios (based on OD600), inoculated in fresh media and grown to ~ OD600 0.03 (minimal 
MOPS with glycerol) or ~OD600 0.1 (LB and minimal MOPS with fructose).  Cultures 
were then exposed to 0.5% αMG or 2DG (Sigma), or kept under non-stress conditions.  
Due to the overall lower growth rate in glycerol, cells grown with glycerol were exposed 
to αMG at lower OD600 and incubated longer.  Culture samples were collected right after 
the initial mixing, as well as 3 hours (LB), 17 hours (minimal MOPS media with 
fructose) or 19 hours (minimal MOPS media with glycerol) after exposure of the cells to 
the stress inducer.  Serial dilutions were made from the collected samples and plated on 
LB agar with or without 100 µg/ml tetracycline.   
For the experiments involving removal of inducers, strains were grown overnight 
in LB or minimal MOPS media supplemented with 0.4% glycerol (25 µg/ml kanamycin 
was added to the media when working with strains carrying plasmids pZE21 and 
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pZEYS2) in the presence of 0.1 mM IPTG and then subcultured 1:200 in fresh media.  25 
ng/ml anhydrotetracycline (aTc) was added to the subcultures when working with strains 
carrying plasmids.  Cells were harvested at ~OD600 0.1 by filtration, washed and 
resuspended in fresh media with 0.5% αMG and in the presence or absence of 0.1mM 
IPTG.  aTc at 25 ng/ml was added back to these cultures when working with strains 
carrying plasmids pZE21 and pZEYS2.   
In other regular growth experiments, strains were grown in minimal MOPS 
medium supplemented with 0.4% glycerol, 25 µg/ml kanamycin and 25 ng/ml aTc to 
~OD600 0.1 and then exposed to 0.5% αMG.  
2.5 RT-PCR 
Strains were grown overnight in LB medium and subcultured 1:200 in fresh 
medium. Total RNA was extracted by the hot-phenol method (132) both before and 10 
min after exposure of the cells to 0.5% αMG.  Reverse transcription (RT) was performed 
with 5 μg of Turbo DNase (Ambion)-treated RNA using the Superscript III reverse 
transcriptase (Invitrogen) and oligonucleotide O-YS110 (Table 2.2).  The PCR products 
were amplified from cDNA using the Go Taq (Promega) PCR system with primers O-
YS101 and O-YS102 (Table 2.2). 
2.6 5ʹ′  RACE 
5′ Rapid amplification of cDNA ends (RACE) analysis of the setA transcript was 
performed as described previously with and without tobacco acid pyrophosphatase to 
detect transcription initiation sites versus processed ends (8) with RNA isolated from 
mid-log-phase wild-type (DJ480) cells grown in minimal MOPS medium supplemented 
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with 0.4% glycerol 10 min following exposure of the cells to 0.5% αMG.  
Oligonucleotide O-YS109 was used for reverse transcription, primers O-YS107 and 
ForPCR-RACE were used for PCR, and O-YS138 was used for sequencing (Table 2.2). 
2.7 Efflux assays 
Strains were grown overnight in minimal MOPS medium supplemented with 
0.4% glycerol and subcultured 1:200 into fresh medium.  The cultures were grown at 
37°C to an OD600 of ∼0.1. The cells were incubated with [14C]αMG (ARC; 3.3 μM; 1 
μCi/ml) at room temperature for 20 min and then diluted 200-fold with fresh medium.  At 
the indicated times, 20 ml of the culture was filtered (Fisher; 25 mm; filter pore size, 0.45 
μm), and the radioactivity of the filtered cells was determined with a scintillation counter. 
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2.8 Tables 
Table 2.1 Bacterial strains and plasmids used in this work 
Strain 
or 
plasmid 
Description Source or reference 
Strain 
MG1655 Wild-type E. coli K12 D. Jin (NCI) 
DJ480 MG1655 ΔlacX74 D. Jin (NCI) 
BAH100 DJ480 imm21 sgrSʹ′-lacZ This study 
BAH101 DJ480 imm21 sgrSʹ′-lacZ, ΔsgrR::cm This study 
CS104 DJ480 ΔsgrS (137) 
CS123 DJ480 sgrS1 (137) 
CS168 DJ480 λattB::lacIq+ tetR Spr This study 
CS194 DJ480 ΔyigL::FRT λattB::lacIq+ tetR Spr This study 
CS195 DJ480 ΔyigL::FRT ΔsgrS λattB::lacIq+ tetR Spr This study 
CV107 DJ480 ΔptsG ΔmanXYZ ΔsgrS C. K. Vanderpool (NIH) 
CV700 DJ480 ΔsgrR::cm (132) 
JH111 DJ480 ΔsgrS λattB::lacIq+ tetR Spr (106) 
JH116 DJ480 ΔsgrS manXʹ′-ʹ′lacZ lacIq+ (106) 
JH171 DJ480 ΔsgrS ptsGʹ′-ʹ′lacZ lacIq+ (106) 
ST101 DJ480 ΔsetA::cm This study 
YS131 DJ480 setAʹ′-lacZ This study 
YS133 DJ480 setAʹ′-lacZ ΔsgrR::cm This study 
YS135 DJ480 sub1 This study 
YS137 DJ480 sub2 This study 
YS140 DJ480 setAʹ′-lacZ sub1 This study 
YS142 DJ480 setAʹ′-lacZ sub2 This study 
YS143 DJ480 ΔsetA::cm λattB::lacIq+ tetR Spr This study 
YS144 DJ480 sgrS1 λattB::lacIq+ tetR Spr This study 
YS185 DJ480 ΔyigL::FRT This study 
YS214 DJ480 imm21 sgrSʹ′-lacZ, ΔsetA::cm This study 
YS215 DJ480 imm21 sgrSʹ′-lacZ, ΔsgrS This study 
YS219 DJ480 setAʹ′-lacZ ΔkdgR::FRT This study 
YS224 DJ480 imm21 sgrSʹ′-lacZ, sgrS1 This study 
YS225 DJ480 imm21 sgrSʹ′-lacZ, ΔkdgR::FRT This study 
YS228 DJ480 imm21 sgrSʹ′-lacZ, Δcrp::cm This study 
YS231 DJ480 setAʹ′-lacZ Δcrp::cm This study 
YS234 DJ480 ΔsgrS yigLʹ′-ʹ′lacZ λattB::lacIq+ tetR Spr This study 
YS236 λattB::tet This study 
YS237 DJ480 λattB::tet This study 
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Table 2.1 (cont.) 
YS238 DJ480 λattB::tet sgrS1 This study 
YS246 DJ480 ΔsgrS::kan-araC-PBAD-ccdB, mini λ This study 
YS247 DJ480 λattB::tet ΔsgrS This study 
YS248 DJ480 sgrS28 This study 
YS249 DJ480 λattB::tet sgrS28 This study 
YS258 DJ480 ΔsgrS cm-Plac-ptsG λattB::lacI
q+ tetR 
Spr This study 
YS259 DJ480 cm-Plac-ptsG λattB::lacIq+ tetR Spr This study 
YS265 DJ480 cm-Plac-ptsG yigL::FRT ΔsgrS 
λattB::lacIq+ tetR Spr This study 
YS269 DJ480 sgrS26 This study 
YS270 DJ480 λattB::tet sgrS26 This study 
YS273 DJ480 λattB::tet ΔyigL::FRT This study 
YS283 DJ480ΔmanXYZ::kan ΔsgrS λattB::tet  This study 
YS284 DJ480ΔptsG::cm ΔsgrS λattB::tet  This study 
YS285 DJ480ΔmanXYZ::kan λattB::tet  This study 
YS286 DJ480ΔptsG::cm λattB::tet  This study
Plasmid   
pHDB3 Vector control for pBRBAH3 (132) 
pBRBAH3 PsgrR-sgrR1 This study 
pBRCS12 Vector control for pLCV1, pBRCS6, pBRJH19, pBR26 and pBRYS4 (137) 
pLCV1 Plac-sgrS  (132) 
pBRCS6 Plac-sgrS1 (137) 
pBRJH26 Plac-sgrS26 (106) 
pBRYS4 Plac-sgrS28 This study 
pZE21 Vector control for pZEYS1 and pZEYS2 (70) 
pZEYS1 PLtetO-1-setA This study 
pZEYS2 PLtetO-1-yigL This study 
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Table 2.2 Oligonucleotides used in this study 
Name 
O-BH102 CCCGGATCCCATCGTTAGGAATTATTGACTTAATATAGG 
O-CV142 CCCGAATTCAAAAGAAACGCCAGTGAAGCGGTG 
O-CV170 TTTTATTCTCGCCGCGCTAAAAAGGGAACGTATGATCTG GATACCTGTGACGGAAGATCACTTCGC 
O-CV171 TTTAACCTTTGCGGTTAAAAATAATGCGACAACAGAAATAACCTTATCACTTATTCAGGCGTAGCACC 
O-CV193 CCCGGATCCGTATTGGGCTTACCTTGCAGCACGAC 
O-YS101 ACCGCAATTCTGAAAGTTGACTTGCC 
O-YS102 GAGCCATCGTCATTATCCAGATCATACG 
O-YS107 CGCCCCGGCCACCCCCATCATAAAA 
O-YS109 ATAGCATTCACCGTATAAAAGA 
O-YS110 CCTGACTGTCAGAACGTTTTGC 
O-YS125 CATTTATGCTGGTCGCTTTTATGATGGGGGTGGCCGGGG CGTGTAGGCTGGAGCTGCTTC 
O-YS126 ACCGCAATTACCCAGTAGACAGCAAAAGTGCCCCCCAA CTTTATTCCGGGGATCCGTCGACC 
O-YS130 CCGGTACCGTGTAAAATCACCCGCCAGCAGATT 
O-YS134 
AACCAGCACAACTTCGCTGTCGCGGTAAAATAGTGCTG
ATAAAACTGACGCATGGGGCACCCCCTTGCTTCATCGTT
AGGAGTTGTTGACTTAATATAGGGAAAAAT 
O-YS135 
GAAAATAAAATTGCTGTCTTTTGCACAGGAGTTCGGGA
ATTATGCCATCTGCTCGTCTGCAACAACAGTTCATCCGC
CTGTGGCAA 
O-YS138 GCCGCGTAAACACCGTTCATACGGC 
For PCR-RACE GATATGCGCGAATTCCTGTAGAACGAAC 
ΔyabNcm1 GCTCGTCTGCAACAACAGTTATCCGCCTGTGGCAATGCTGCCTGTGACGGAAGATCACTTCGC 
ΔyabNcm2 GGGTATTCATGCGCAGGCCGCGCATACTGCGTTGCCCTGTTATCACTTATTCAGGCGTAGCACC 
O-YS156 CCCAGCGGAAACCGCTCTACAGAGGTTTAAATTTCTTGTGTAGGCTGGAGCTGCTTCG 
O-YS157 GCGAAGTATCAGGTTGACAACTGACCAAATAAAGAACGAATTCCGGGGATCCGTCGAC 
O-YS206 CATACGTTATCCCCTTACGCCAAAGAACTCTGAAGCTGATTCCGGGGATCCGTCGA 
O-YS207 GTATCCATTGTAGCGAAGTATCAGGTTGACAACTGACCAGTGTAGGCTGGAGCTGCT 
O-YS212 TGAAAGTTGACTTGCCTGCATCATCACACACTGAGTATTGGTGTAAAATCACCCGC 
O-YS213 ACCTTCCCGTTTCGCTCAAGTTAGTATAAAAAAGCACTAGACATCATTAATTCCTA 
O-YS214 CCGGGCTATGAAATAGAAAAATGAATCCGTTGAAGCCGAAGCTAAATCTTCTTTATC 
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Table 2.2 (cont.) 
O-YS215 CCCAAGCTTATTAAAGAGGAGAAATTAACTATGTACCAGGTTG TTGCGTCTGAT 
O-YS216 CCCGGATCCCCAAATAAAGAACGATTACGATAAATAGAGTTTACGCAGA 
O-YS225 CCTGTGACGGAAGATCACTTCGCAGAATAA 
O-YS226 CAGTGGGATGACCGCAATTCTGAAAGTTGACTTGCCTGCAATAGGAACTTCAAGATCC 
O-YS227 TACGGCGAGCCATCGTCATTATCCAGATCATACGTTCCTTATATTCCCCAGAACATCAGG 
O-YS228 CAGTGGGATGACCGCAATTCTGAAAGTTGACTTGCCTGCATCATCACACACTGAGTATT 
O-YS230 TACGGCGAGCCATCGTCATTATCCAGATCATACGTTCCC 
O-YS238 GTGCTCAGTATCTTGTTATCCGCTCACAATGTCAATGTTATCC GCTCACATTTATTTATCCGCTCACATTTATTTATCACTTAT 
O-YS240 AGCTCGTAATTAATGGCTAAAACGAGTAAAGTTCACCCCTGT GACGGAAGATCACTT 
O-YS241 CCTCGCCGTGTACAGGGCATCTAAGCGCCCTTTATTTATGTGC TCAGTATCTTGTTATC 
O-YS261 CAGTGGGATGACCGCAATTCTGAAAGTTGACTTGCCTGCATCA TCTGTGACTGAGTATT 
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CHAPTER 3:  MULTIPLE TARGET REGULATION BY SGRS 	  
3.1 Introduction 
Under GP stress, SgrS sRNA base pairs with mRNAs and regulates their 
translation and stability.  The two confirmed negative mRNA targets of SgrS are ptsG 
(132) and manXYZ (106), which encode major PTS transporters of glucose and mannose 
respectively.  In addition, SgrS positively regulates stability of the yigL mRNA, which 
encodes a phosphatase implicated in the GP stress response (91).  In general, SgrS 
activity mitigates stress and allows cells to continue growing. 
Most studies so far have focused on the molecular mechanisms of individual 
target regulation by SgrS, and these have revealed novel and interesting aspects of sRNA-
mediated regulation.  However, it is unknown how coordinated regulation of these 
multiple targets contributes to the GP stress response.  In this chapter, we sought to 
identify evidence of coordinate regulation by SgrS, hypothesizing that regulation of some 
targets would be more important than others in terms of rescuing cell growth during 
stress, and that this arrangement might change to match fluctuations in the environment.  
Though it seemed less likely, we considered that control of all SgrS regulon members 
could contribute equally to stress recovery, albeit through independent mechanisms.  To 
address this hypothesis, we began by testing how SgrS regulation of different targets 
impacts growth in response to different inducers of GP stress (αMG or 2DG), in varying 
nutrient environments.  We demonstrated that SgrS regulon members contribute 
differentially to the stress response depending upon the particular source of stress, and 
these relative physiological contributions change with nutrient fluctuations.  These results 
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show that regulation of only a subset of SgrS targets is important for responding to a 
given stressor in a particular environment.  
3.2 Results 
3.2.1 Mutations in SgrS base pairing determinants have differential effects on 
regulation of three targets 
Previous studies have demonstrated that duplex formation between SgrS and its 
target mRNAs is essential for regulation.  For each of the targets, the residues of SgrS 
involved in pairing partially overlap and are partially distinct.  For example, though two 
G-C base pairs formed by SgrS residues G176 and G178 (Fig. 3.1A) are critical for 
translational repression of ptsG by SgrS (53), they are not required for inhibition of manX 
translation (106).  We sought to identify additional mutations in sgrS that would result in 
differential target regulation.  Regulation by wild-type and mutant SgrS was monitored 
using translational lacZ fusions to the three known SgrS targets.  As shown in Fig. 3.1B, 
wild-type SgrS (expressed from a plasmid under the control of the Plac promoter) 
repressed ptsGʹ′-ʹ′lacZ (~3-fold repressed compared to vector control) and manXʹ′-ʹ′lacZ 
(~3-fold repressed) and activated yigLʹ′-ʹ′lacZ (~4.4 fold increase compared to vector 
control).  These results were consistent with previous reports (91, 106).  The sgrS allele 
with G176C and G178C mutations (Fig. 3.1A), which we refer to as sgrS1, repressed 
manXʹ′-ʹ′lacZ almost as efficiently as wild-type SgrS, but no longer regulated the activities 
of ptsGʹ′-ʹ′lacZ (as observed previously, (106)) but also of yigLʹ′-ʹ′lacZ (Fig. 3.1B).  Thus, 
with regard to these three targets, SgrS1 specifically regulated only manXYZ and is 
hereafter referred to as SgrS1manXYZ.  SgrS28 is an SgrS allele that carries five point 
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mutations (G172C, T171A, G170C, T169A, G168C, Fig. 3.1A).  When expressed from 
the Plac plasmid, SgrS28 repressed ptsGʹ′-ʹ′lacZ to a degree similar to wild-type SgrS (Fig. 
3.1B) but failed to regulate either manXʹ′-ʹ′lacZ or yigLʹ′-ʹ′lacZ (Fig. 3.1B).  Since SgrS28 
specifically regulated only ptsG, it is referred to as SgrS28ptsG.  A previous study in our 
laboratory identified the sgrS26 allele (Fig. 3.1A), with a G168C mutation, as being 
defective for regulation of manXʹ′-ʹ′lacZ (106).   We confirmed this finding, and further 
showed that SgrS26 repressed ptsGʹ′-ʹ′lacZ activity and enhanced yigLʹ′-ʹ′lacZ activity to a 
degree similar to wild-type SgrS (Fig. 3.1B).  Since SgrS26 regulated both ptsG and yigL, 
but was deficient in regulation of manXYZ, it is now referred to as SgrS26ptsG,yigL. 
3.2.2 Regulation of ptsG, but not manXYZ or yigL, is crucial for recovery from αMG-
induced stress in nutrient-rich medium 
In order to verify that differences in regulation were not due to decreased stability 
of mutant sRNAs, we tested the induction of chromosomally-encoded sgrS mutant alleles 
in response to αMG and monitored stability using a rifampicin chase (Fig. 3.1C).  After 
aMG treatment, all three mutant SgrS molecules were present at levels similar to wild-
type and also showed similar stabilities  (Fig. 3.1C).  These results suggested that 
observed differences in regulation of targets are not due to effects on SgrS stability. 
To determine whether target-specific mutant alleles have the ability to cope with 
different types of GP stress in different nutritional environments, we first checked stress 
induced by αMG under nutrient-rich conditions.  To examine abilities of strains carrying 
sgrS mutant alleles to cope with GP stress, growth competition experiments were 
conducted as described in Materials and Methods, using αMG as the stressor.  Briefly, 
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the two indicated strains were mixed at a 1:1 ratio in LB medium.  The mixed culture was 
exposed to αMG at early log phase and then was grown to saturation.  The number of 
viable cells at both the initial mixing and the end of the experiment were determined by 
plating for colony forming units (CFU), and a competition index (58) was calculated as 
follows: (log10 strain A recovered/log10 strain B recovered)/(log10 strain A inoculated/log10 
strain B inoculated).  A CI equal to 1 indicates that the two strains compete evenly for 
resources in mixed culture; a CI that is less than 1 suggests that strain B outcompetes 
strain A, whereas a CI that is greater than 1 shows that strain A outcompetes strain B.   
As a control, we first compared the growth of a strain marked with tetracycline 
resistance at a neutral genomic location (attB::tet) with the wild-type parent.  The CI for 
the attB::tet versus wild-type parent was ~1.0 in both the absence and presence of αMG 
(Table 3.1).  This result demonstrated that the tetracycline-resistance gene does not cause 
a growth defect under these conditions.  As shown in Table 3.1, in the absence of stress 
(LB medium without αMG), all strains competed equally, indicating that SgrS does not 
play a significant role in E. coli growth in rich medium.  In contrast, under αMG-induced 
stress conditions, growth of the ΔsgrS mutant was significantly attenuated when it 
competed with the wild-type strain (CI = 0.6), which is consistent with the important role 
of SgrS in the GP stress response, as reported previously (132).  The sgrS1manXYZ mutant, 
which specifically regulates manXYZ but not ptsG or yigL (Fig. 3.1), also exhibited a 
severe growth defect in competition with the wild-type strain (CI = 0.5, Table 3.1).  The 
CI for the sgrS1manXYZ mutant versus the ΔsgrS mutant was 1.0 (Table 3.1), indicating that 
SgrS regulation of manXYZ alone gives no growth advantage when cells are stressed by 
αMG.  In contrast, the strain with the sgrS28ptsG allele that allows regulation of ptsG but 
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not manXYZ or yigL, competed equally with the wild-type strain (CI = 0.8, P value 
indicates not significant, Table 3.1), and outcompeted the other two sgrS mutants (Table 
3.1).  These results strongly suggested that during growth with αMG in rich medium, 
regulation of ptsG, which encodes the major transporter of αMG (108),  is a crucial 
function of SgrS in the stress response, whereas regulation of manXYZ and yigL appears 
dispensable.  Consistent with this notion, both a ΔmanXYZ mutant (CI = 1.02) and a 
ΔyigL mutant (CI =1.05) strain competed equally with the wild type strain during growth 
in rich medium with αMG (Table 3.2).  In addition, a ΔmanXYZ ΔsgrS double mutant 
also showed similar growth to its ΔsgrS parent (CI =1.08, Table 3.2).  On the other hand, 
a ΔptsG mutant outcompeted the wild type strain (CI = 2.6), and a ΔptsG ΔsgrS double 
mutant outcompeted its ΔsgrS parent strain (CI = 2.26) during growth with αMG (Table 
3.2), most likely because uptake of the stress-causing αMG was blocked in these mutant 
cells, which lacked the major transporter PtsG. 
One limitation of using sgrS base pairing mutants is that the mutations may affect 
the ability of SgrS to regulate other as-yet-unknown mRNA targets.  Transcriptome 
analyses conducted in our laboratory have suggested that in addition to ptsG, manXYZ 
and yigL, there are other target mRNAs whose expression is altered by SgrS, some of 
which may be involved in the GP stress response (M. Bobrovskyy, G. Richards, D. 
Balasubramanian, and C. K. Vanderpool, unpublished data).  It is possible that the sgrS 
mutations carried by strains used in our growth competition experiments disrupt the base 
pairing interactions between SgrS and some of these other putative targets, which may 
affect recovery from stress.  To address this issue, we tested whether specific down-
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regulation of ptsG by an SgrS-independent mechanism would allow efficient growth 
rescue of sgrS mutant cells stressed by αMG in rich medium.  A Plac promoter was 
inserted in front of the ptsG gene on the chromosome in order to control its expression at 
the level of transcription.  By removing the inducer IPTG, new synthesis of PtsG 
(EIICBGlc) protein can be stopped via turning off ptsG transcription, in a manner that is 
independent of SgrS function.  Wild-type, ΔsgrS, Plac-ptsG and ΔsgrS Plac-ptsG strains 
were grown in pure cultures in LB medium with IPTG to early log phase.  Cells were 
harvested, washed and resuspended in fresh medium with αMG and without IPTG.  If 
stopping new synthesis of PtsG were sufficient for recovery from stress, we expected that 
the ΔsgrS Plac-ptsG strain would show better growth than the ΔsgrS parent.  As expected, 
sgrS+ cells grew well under stress conditions, regardless of the transcriptional control of 
ptsG (Fig. 3.2A, compare solid diamonds [WT] to open triangles [Plac-ptsG]).  This 
indicated that in the presence of SgrS, growth recovery under αMG stress conditions was 
not significantly affected by turning off transcription of Plac-ptsG (by removal of IPTG).  
In contrast, in the ΔsgrS mutant background, cells with Plac-ptsG recovered significantly 
better than cells expressing ptsG from its native promoter (Fig. 3.2A, compare open 
squares [ΔsgrS] to “X” symbols [ΔsgrS Plac-ptsG]).  This result suggested that in the 
absence of SgrS, cell growth in the presence of αMG can be rescued by turning off new 
PtsG synthesis by an SgrS-independent mechanism, i.e., stopping ptsG transcription.  On 
the other hand, when IPTG is persistently present in the culture media (i.e., IPTG was 
added back following the washout), the Plac-ptsG strains both grew more poorly than the 
strains where ptsG is expressed from its native promoter (Figs. 3.2B) following exposure 
of the cells to αMG (Fig. 3.2B).  This is consistent with the idea that inhibition of PtsG 
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synthesis is one of the primary adaptive effects mediated by SgrS under αMG stress 
conditions in rich medium.   
3.2.3 SgrS-mediated regulation of ptsG and yigL, but not manXYZ, is required for 
recovery from αMG stress in certain minimal media 
We reported previously that sgrS mutant strains have more pronounced growth 
defects when GP stress is induced in minimal medium compared with rich medium (121).  
Therefore, we were interested in determining how regulation of different SgrS targets 
contributed to growth recovery in the more stringent stress induced in minimal media.  
We consequently tested growth competition between wild-type and sgrS mutant strains 
grown with αMG as the stressor in minimal MOPS media with either glycerol (Table 3.3) 
or fructose (data not shown) as the sole carbon source.  When fructose was the sole 
carbon source, the results of competition between all strains were very similar to those 
for competitions in LB with αMG (Table 3.1; data not shown) and will therefore not be 
discussed further.  The attB::tet marker had no effect on growth without or with αMG 
when cells were grown in minimal medium with glycerol (Table 3.3), and all strains 
competed evenly in the absence of the stressor (Table 3.3, -αMG).  When cells were 
stressed with αMG, both the ΔsgrS (CI = 0.38, Table 3.3) and sgrS1manXYZ mutants (CI = 
0.42, Table 3.3) were at a significant growth disadvantage compared to the wild-type 
cells, whereas they competed evenly with one another (CI = 1.01, Table 3.3).  These 
results are consistent with the notion that the regulatory action of SgrS on manXYZ does 
not play a significant role in a successful stress response to αMG in minimal medium.  In 
addition, both the ΔmanXYZ mutant (CI = 1.02) and the ΔmanXYZ ΔsgrS mutant (CI = 
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0.97) competed equally with their respective manXYZ+ strains during growth in minimal 
medium with αMG (CI = 1.02, Table 3.4), most likely because ManXYZ is not the 
primary transporter responsible for αMG uptake.  This replicated the pattern of growth 
competition seen for the same strains in rich medium (Table 3.1, 3.2).  However, in 
contrast to the rich medium experiments, growth of the sgrS28ptsG mutant was severely 
attenuated in competition with the wild-type strain in glycerol minimal medium with 
αMG (CI = 0.34, Table 3.3).  In fact, under these severe stress conditions, the sgrS28ptsG 
mutant competed evenly with the sgrS1manXYZ mutant (CI = 1.02, Table 3.3) and the ΔsgrS 
mutant (CI = 1.11, Table 3.3).  On the other hand, under the same conditions, the ΔptsG 
mutant outcompeted the wild type strain (CI = 2.87) and the ΔptsG ΔsgrS mutant grew 
much better than its ΔsgrS parent strain (CI = 2.23, Table 3.4), suggesting that fully 
blocking αMG uptake by removing its major transporter PtsG can effectively prevent 
stress.  However, if stress is induced in a ptsG+ strain, our results suggest that SgrS must 
block new PtsG synthesis and perform other functions.  Together, these results suggested 
that when cells are stressed while growing in minimal medium with glycerol, regulating 
ptsG is not the only crucial contribution of SgrS to the stress response, and regulation of 
other targets is also required. 
It was recently reported that yigL also plays a critical role in the GP stress 
response (91).  Here, we tested a ΔyigL mutant for growth in competition with its wild-
type parent in minimal MOPS medium with glycerol and αMG and found the ΔyigL 
mutant to be at a significant disadvantage (CI = 0.26, Table 3.4).  Under these conditions, 
the ΔyigL mutant competed evenly with the ΔsgrS mutant (CI = 1.0, Table 3.4), implying 
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that yigL plays an essential role in recovery from stress in minimal medium.  We 
speculated that cells expressing sgrS28ptsG fail to grow well in minimal medium with 
αMG because SgrS28ptsG cannot regulate yigL.  We therefore tested the hypothesis that 
SgrS regulation of both ptsG and yigL is required for growth recovery from αMG stress 
in minimal medium by competing a strain expressing sgrS26ptsG, yigL (which expresses 
SgrS capable of regulating ptsG and yigL, Fig. 3.1A,B) with wild-type cells.  
Interestingly, the sgrS26ptsG, yigL mutant still displayed a growth deficit in competition with 
the wild-type strain (CI = 0.5, Table 3.3).  Nevertheless, sgrS26ptsG, yigL out-competed both 
the ΔsgrS (CI = 1.86, Table 3.3) and the sgrS1manXYZ (CI = 1.75, Table 3.3) mutants and 
also showed a growth advantage over the sgrS28ptsG mutant (CI = 2.09, Table 3.3).  These 
results indicated that in minimal glycerol medium with αMG as stressor, regulation of 
yigL in addition to ptsG by SgrS is more beneficial than regulation of ptsG alone.  
However, regulating these two targets is not fully sufficient for recovery from stress. 
To further test the contributions of ptsG and yigL regulation to recovery from 
αMG-induced stress and avoid the complication of sgrS base pairing mutations affecting 
regulation of other mRNA targets, we again employed the ΔsgrS Plac- ptsG strain, where 
the expression of ptsG can be manipulated in an SgrS-independent fashion.  In this strain 
background, yigL was deleted from the chromosome and expressed in trans from the 
inducible PLtetO-1 promoter.   Strains were grown and stressed in minimal MOPS medium 
supplemented with glycerol and αMG.  As a control, we first examined the ΔyigL 
phenotype and complementation by the plasmid carrying PLtetO-1-yigL.  As observed 
previously (91), the yigL mutant is immediately and strongly inhibited by the addition of 
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αMG to cultures growing in minimal MOPS medium with glycerol (Fig. 3.3A), even 
though these cells produce SgrS.  Induction of the plasmid-borne copy of yigL restored a 
wild-type pattern of growth to the ΔyigL mutant, confirming that the plasmid 
complements the yigL growth defect when SgrS is present (Fig. 3.3A).  The ΔsgrS ΔyigL 
double mutant experienced immediate growth inhibition similar to the ΔsgrS and ΔyigL 
parent strains (Fig. 3.3B).  However, plasmid-encoded yigL failed to significantly 
improve growth of the ΔsgrS ΔyigL double mutant with αMG (Fig. 3.3B).  This suggests 
that other yet-to-be confirmed targets of SgrS are also crucial for the stress response 
under these conditions. 
By controlling ptsG and yigL transcriptional repression or induction, respectively, 
independent of SgrS, we could test how coordinated regulation of these two targets 
contributes to growth during αMG stress in minimal medium.  In accordance with 
previous results (Fig. 3.3B), wild-type cells recovered from αMG stress, whereas ΔsgrS 
cells were severely growth inhibited (Fig. 3.3C).  The growth of ΔsgrS ΔyigL Plac-ptsG 
cells carrying the vector control was similarly growth inhibited, even though ptsG 
transcription was turned off (by removal of IPTG), validating the results of growth 
competition experiments (Table 3.3) that showed that repression of ptsG alone (by the 
SgrS28ptsG mutant) was not sufficient to provide a growth advantage in minimal medium 
with αMG.  The PLtetO-1-yigL plasmid was introduced into the ΔsgrS ΔyigL Plac-ptsG strain 
and transcription of yigL was induced and ptsG was repressed (by addition or removal of 
the appropriate inducer) concomitant with addition of αMG.  Nevertheless, these cells 
still failed to recover from stress (Fig. 3.3C), reinforcing the idea that under these 
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conditions, regulation of both ptsG and yigL by SgrS is necessary, but not sufficient for 
E. coli cells to recover from αMG-induced stress.	  
3.2.4 SgrS-mediated regulation of manXYZ becomes crucial under different stress 
conditions 
The experiments described so far establish that when GP stress is induced by 
αMG, the regulatory action of SgrS on ptsG plays a much more prominent role in stress 
recovery than regulation of manXYZ (Table 3.1~3.4 and Fig. 3.2).  These results are 
consistent with the substrate preferences of these two PTS transporters:  EIICBGlc (PtsG) 
has a higher Vmax for αMG and EIIABCDMan has a higher Vmax for the glucose analog 2-
deoxyglucose (2DG) (1, 42, 104, 118).  Similarly, PtsG plays a bigger role in induction of 
the stress response due to its transport of αMG, while ManXYZ leads to stress response 
induction by 2DG (106).  We therefore theorized that regulation of manXYZ by SgrS 
might be more important during 2DG-induced stress.  To test this hypothesis, we first 
examined growth competition between wild-type and sgrS mutant strains stressed in 
minimal MOPS media with fructose (Table 3.5), because it was observed previously that 
E. coli cells growing under this condition experienced sugar phosphate stress when 
exposed to 2DG.  Under 2DG-induced stress conditions, the ΔsgrS mutant was at 
significant growth disadvantage in competition with the wild-type strain (CI = 0.46, 
Table 3.5), highlighting the crucial role of SgrS in mitigating 2DG-induced stress.  
Interestingly, the sgrS1manXYZ mutant, which specifically regulates manXYZ but not ptsG or 
yigL (Fig. 3.1), competed equally with the wild-type strain (CI = 1.03, Table 3.5) and 
outcompeted the ΔsgrS mutant (CI = 2.25, Table 3.5).  On the other hand, the strain with 
sgrS28ptsG that allows regulation of ptsG but not manXYZ or yigL, was at a growth 
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disadvantage compared with both the wild-type (CI = 0.68, Table 3.5) and the sgrS1manXYZ 
strain (CI = 0.59, Table 3.5).  Similar results were observed when glycerol was used as 
the sole carbon source (data not shown).  
Consistent with the observations described above, the ΔmanXYZ mutant 
outcompeted the wild type strain (CI = 2.04) and the ΔmanXYZ ΔsgrS mutant was at a 
growth advantage compared to its ΔsgrS parent during growth with 2DG, most likely due 
to lack of 2DG uptake in the absence of the major transporter ManXYZ.  Both the ΔptsG 
(CI = 0.98) and the ΔptsG ΔsgrS mutant (CI = 1.08) strains competed evenly with their 
respective parent strains under the same conditions (Table 3.6), which was consistent 
with the notion that PtsG is not primarily responsible for 2DG uptake.  In addition, the 
ΔyigL mutant also showed similar growth (CI = 0.92, Table 3.6) with the wild type 
strains in minimal medium with fructose in the presence of 2DG, indicating that YigL is 
unlikely to play any significant role in the cellular response to this stressor under the 
tested conditions.   We further tested the effect of YigL on growth with 2DG in minimal 
media, using the yigL+ plasmid under the inducible PtetO-1 promoter.  While the wild type 
strains recovered from the stress, the plasmid-born copy of YigL failed to improve the 
growth of the ΔsgrSΔyigL mutant in the presence of 2DG (Fig. 3.3D), which was 
consistent with the results in the growth competition experiments (Table 3.6).  Together, 
these results strongly suggested that recovery from stress induced by 2DG requires SgrS-
mediated regulation of manXYZ, whereas regulation of ptsG and yigL is dispensable for 
the response to 2DG. 
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3.2.5 Nutrient supplementation of minimal media improves growth during GP stress 
Our results so far have demonstrated that variations in nutrient contents of the 
growth media can influence GP stress-associated growth phenotypes, as well as SgrS-
mediated stress response, particularly when αMG is the stressor.  To further investigate 
this phenomenon, we compared growth of the ΔsgrS mutant to the wild type strain under 
αMG stress conditions, in minimal media with fructose or glycerol and in the presence or 
absence of additional supplementation of Casamino acids (Fig. 3.4).  In both media, the 
presence of Casamino acids improved the growth of wild type cells with αMG (Fig. 3.4A 
and C, compare WT + αMG with WT + αMG + CAA), with a more dramatic effect in 
minimal media with fructose.  Supplement of Casamino acids also improved growth of 
the αMG-stressed ΔsgrS mutant in both media (Fig. 3.4A and C, compare ΔsgrS + αMG 
with ΔsgrS + αMG + CAA), albeit at later growth phases (approximately 12 hours 
following exposure of the cells to αMG).  In addition, under non-stress conditions in both 
media, Casamino acids also had positive effect on growth of the wildtype strain and the 
ΔsgrS mutant (Fig. 3.4 B and D).  These results were reminiscent of the difference of GP 
stress-associated growth phenotypes in rich versus minimal media, which was consistent 
with the impact of nutrient availability on cell growth and response to GP stress.  
3.3 Discussion 
In recent years, hundreds of novel sRNAs have been identified in E. coli, 
Salmonella and many other bacterial species.  However, SgrS is one of only a few base 
pairing sRNA regulators for which we have detailed knowledge concerning its regulation, 
targets and perhaps most importantly, a clearly-associated growth phenotype.  These 
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features make SgrS an excellent model for unraveling molecular mechanisms of sRNA-
mediated coordinate regulation and unifying these with their physiological relevance.  In 
this chapter, we began to investigate the physiological impact of sRNA regulation of 
multi-target regulons.  This issue is broadly relevant, since current evidence indicates that 
most if not all Hfq-dependent sRNAs regulate multiple mRNA targets (116). 
Identification of SgrS mutants with altered target specificities allowed us to assess 
the importance of SgrS-mediated regulation of different targets under a variety of 
conditions.  One stress variable that we manipulated was the stress-inducing 
phosphosugar.  The two sugars we used, αMG and 2DG, are both glucose analogs, but 
are taken up via distinct PTS transporters, PtsG and ManXYZ, respectively (1, 42, 104, 
118).  We found that when αMG was the stressor, SgrS regulation of ptsG was crucial for 
continued growth, both in the context of growth competition (Table 3.1) and when strains 
were growing in pure culture (Fig. 3.2).  In contrast, regulation of manXYZ by SgrS 
conferred no growth advantage during αMG-induced stress (Table 3.1).  On the other 
hand, when cells were stressed by uptake of 2DG, regulation of manXYZ by SgrS was 
crucial whereas regulation of ptsG was dispensible (Table 3.5).  These data suggest that 
the importance of SgrS regulating particular targets fluctuates depending on the source of 
GP stress, and that regulating only a subset of targets may be important under a given 
stress-inducing condition (Fig. 3.5). 
By varying the nutrients available to cells by culturing in rich or minimal media, 
we discerned that factors other than the sugar stressor can modulate GP stress-associated 
growth phenotypes.  Cells stressed with αMG show different patterns of growth 
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depending on the nutrient content of the medium.  In rich (LB) medium, wild-type and 
sgrS mutant cells continue growing for ~2 generations after αMG exposure.  After that, 
growth of wild-type cells is unaffected, while sgrS mutant growth slows dramatically 
((132) and Fig. 3.1).  In contrast, when growing in minimal medium, both wild-type and 
sgrS mutant cells experience almost immediate inhibition after exposure to αMG ((121) 
and Fig. 3.3B).  Wild-type cells subsequently recover, but sgrS mutant growth remains 
inhibited (Fig. 3.3B).  The results of our experiment with casamino acid supplementation 
to the minimal media (Fig. 3.4) suggested that it is likely the amino acid component of 
the rich media that reduces the severity of stress compared to minimal media.  Perhaps 
the supplementation of these components to the media contributes to the cellular recovery 
by diminishing the drain on central metabolites or lessening energy demand for growth 
under GP stress. 
Interestingly, 2DG is apparently not as stringent a stressor as αMG.  While 2DG 
uptake induces the stress response in rich media, as measured by induction of sgrS 
transcription (106), neither wild-type nor sgrS mutant strains have a discernible 2DG-
associated growth phenotype when growing in rich media (data not shown).  However, 
when cells are growing in minimal media with 2DG, sgrS mutant cells have a significant 
growth disadvantage compared to wild-type cells (Table 3.5).  While the important 
functional differences between αMG and 2DG with respect to GP stress induction have 
not yet been uncovered, these observations highlight the fact that the severity of GP 
stress-associated growth inhibition depends on cellular nutrition status.  
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In addition to nutrient-dependent GP stress growth phenotypes, we found that 
regulation of different SgrS target subsets is required when cells are stressed in nutrient-
rich versus nutrient-poor environments.  When cells are stressed with αMG during 
growth in rich media or with 2DG in minimal media, SgrS is primarily needed to regulate 
the mRNAs encoding the relevant sugar transporters (Tables 3.1 and 3.5, Figs. 3.1 and 
Fig. 3.3).  In contrast, when cells are stressed with αMG in minimal media, regulation of 
ptsG alone is no longer sufficient to rescue cell growth (Table 3.3 and Figs. 3.3).  Instead, 
the data indicate that SgrS regulation of the phosphatase mRNA (yigL), as well as other 
unknown targets is also required. 
Sensitivity of GP stress phenotypes to nutrient availability may reflect coupling of 
central carbon metabolism and other metabolic pathways.  It is known that in many 
organisms, carbon transport and utilization is regulated in response to the availability of 
other nutrients such as nitrogen and phosphorus in the environment.  However, in most 
cases, the regulatory mechanisms that link metabolic pathways are not understood.  Just 
last year, a novel regulatory connection between central carbon metabolism and nitrogen 
assimilation was uncovered in E. coli.  Researchers in the Rabinowitz group found that 
α-ketoglutarate (αKG), a TCA cycle intermediate that feeds into the nitrogen 
assimilation pathway, allosterically inhibits the general PTS protein Enzyme I (EI) (28).  
Buildup of excess αKG appears to signal that carbon is in excess relative to nitrogen, so 
αKG inhibition of EI serves to reduce uptake of carbon through the PTS and bring flux 
through carbon and nitrogen pathways back into balance.  Interestingly in our study, 
supplementation of Casamino acids to the media improves cell growth with αMG (Fig. 
3.4).  Casamino acids contain an abundant amount of glutamate (21.1%) that can be 
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converted to αKG by E. coli cells (35).  It’s possible that αKG generated from Casamino 
acids inhibits EI activity, which in turn reduces uptake of αMG and improves cellular 
growth.  Based on these results, we hypothesize that the GP stress response might control 
the interplay between central carbon metabolism and another metabolic pathway.  
Consistent with this idea, a recent study conducted in our laboratory revealed that 
induction of the phosphate starvation (Pho) regulon ameliorates growth inhibition of an 
sgrS mutant, suggesting that phosphate and carbon metabolism are both linked to GP 
stress (108).  We speculate GP stress causes not only a buildup of upstream 
phosphosugars, but also depletes downstream glycolytic metabolites, such as 
phosphoenolpyruvate, which is the phosphate donor that activates PTS transporters such 
as PtsG and ManXYZ.  It is conceivable that nutrients available in rich medium provide 
metabolites that are made limiting by GP stress, thus mitigating stress-associated growth 
inhibition and precluding the need to regulate SgrS targets other than sugar transporter 
mRNAs.  These factors would not be available in nutrient-poor minimal medium, perhaps 
leading to the requirement for SgrS regulation of additional targets, perhaps encoding 
metabolic genes, to rescue cell growth.  
Taken together, our results suggest that SgrS and perhaps other sRNAs have 
evolved to be flexible regulators that modulate expression of multi-gene regulons in order 
to allow cells to adapt to an array of related stress conditions.  We demonstrated that 
regulation of only a subset of sRNA targets is important in a given environment.  
Research to define other members of the SgrS regulon is underway, and identification of 
other SgrS targets will lead to new insights into the physiology of glucose-phosphate 
stress.  
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3.4 Figures and Tables 
 
Fig. 3.1 SgrS mutant alleles differentially regulate expression of ptsG, manX and 
yigL.  A. Base pairing between SgrS and the three targets ptsG, manX and yigL mRNA 
are indicated by vertical lines.  The sequence directly above SgrS and allele names 
(SgrS1, SgrS26 and SgrS28) indicate the mutated bases and their positions in different 
SgrS mutants.  B. The ΔsgrS strains with ptsGʹ′-ʹ′lacZ, manXʹ′-ʹ′lacZ or yigLʹ′-ʹ′lacZ carrying 
an empty vector, Plac-sgrS, Plac-sgrS1, Plac-sgrS26 or Plac-sgrS28 were grown to early log 
phase and exposed to 0.1mM IPTG.  Samples were collected 60 minute after IPTG 
addition and assayed for β-galactosidase activities.  Specific activities were normalized to 
the levels in the strains carrying the empty vector to yield fold relative activity.  C.  
Strains were grown to early log phase and exposed to 0.5% αMG for 10 minutes.  250 
µg/ml rifampicin was then added to all cultures and RNA samples were harvested at the 
indicated time points and subjected to northern blot analysis. 	    
	   63	  
	  
Fig. 3.2 Regulation of ptsG by SgrS is crucial for recovery from αMG-induced stress.  
Strains were grown in LB media overnight and then subcultured 1:200 in fresh media, 
both in the presence of 0.1mM IPTG.  Cells were harvested at ~OD600 0.1 by filtration, 
washed and resuspended in fresh media with 0.5% αMG and A. in the absence or B. 
presence of 0.1mM IPTG.  Growth of all cultures was monitored by OD600 throughout the 
whole procedure, but only the measurements following resuspension of cells were 
reported in the graphs.  
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Fig. 3.3 SgrS-mediated regulation of multiple targets, including ptsG, yigL and 
additional targets, is required for recovery from αMG-induced stress.  A. & B. 
Strains were grown in minimal MOPS media supplemented with 0.4% glycerol in the 
presence of 25ng/ml aTc to an OD600 of ~0.1 and then exposed to 0.5% αMG.  C.  Strains 
were grown overnight in minimal MOPS media supplemented with 0.4% glycerol and 
25µg/ml kanamycin, and then subcultured 1:200 in fresh media, both in the presence of 
0.1mM IPTG.  25ng/ml aTc was also present in the all subcultures.  Cells were harvested 
at ~OD600 0.1 by filtration, washed and resuspended in fresh media with 0.5% αMG and 
25ng/ml aTc. Growth of all cultures was monitored by OD600 throughout the whole 
procedure, but only the measurements following resuspension of cells were reported in 
the graphs.  D.  Strans were grown in minimal MOPS media supplemented with 0.2% 
fructose in the presence of 25ng/ml aTc to an OD600 of ~0.1 and then exposed to 0.5% 
αMG.
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Fig. 3.4 Supplementation of casamino acid improves growth during GP stress.  
Strains were grown in minimal MOPS media supplemented with A. & B. 0.2% fructose 
or C. & D. 0.4% glycerol.  0.5% αMG and/or 0.1% casamino acid were also present in 
the media as indicated.  
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Table 3.1 Competition assays to measure the effects of sgrS mutations on growth 
with αMG in LB medium 
E. coli  strain A  
genotype 
E. coli  strain B  
genotype 
-αMG + 0.5% αMG  
CIa (n=3) p-valueb CIa (n=3) p-valueb 
λattB::tet WT 1.08 ± 0.06 NS 1.0 ± 0.3 NS 
ΔsgrS  
λattB::tet WT 0.82 ± 0.01 NS 0.6 ± 0.1 0.024 
sgrS1manXYZ 
  λattB::tet WT 0.98 ± 0.21 NS 0.5 ± 0.04 0.01 
sgrS28ptsG 
 λattB::tet WT 0.93 ± 0.08 NS 0.8 ± 0.07 NS 
sgrS1manXYZ  
λattB::tet ΔsgrS 1.02 ± 0.15 NS 1.0 ± 0.01 NS 
sgrS28ptsG 
 λattB::tet ΔsgrS 0.97 ± 0.12 NS 3.5 ± 0.3 0.03 
sgrS28ptsG 
 λattB::tet sgrS1manXYZ 1.03 ± 0.08 NS 2.9 ± 0.1 0.013 
 
a. See Materials and Methods for detailed procedures. CI, Competition Index, is 
calculated as follows: (log10 strain A output / log10 strain B output)/ (log10 strain A 
input / log10 strain B input).  The results presented here are the averages and 
standard deviations of three independent experiments. 
b. Student’s t test was used to compare the output and the inoculums.  NS, not 
significant (P ≥ 0.05). 
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Table 3.2 Competition assays to measure the effects of mutations in the three sgrS 
targets on growth with αMG in LB medium 
E. coli  strain A  
genotype 
E. coli  strain B 
genotype 
-αMG + 0.5% αMG  
CIa (n=3) p-valueb CIa (n=3) p-valueb 
ΔptsG  
λattB::tet WT 0.96 ± 0.05 NS 2.6 ± 0.1 2.0E-5 
ΔmanXYZ   
λattB::tet WT 1.01 ± 0.1 NS 1.05 ±0.04 NS 
ΔsgrS ΔptsG  
λattB::tet ΔsgrS 1.02 ± 0.03 NS 2.26 ±0.18 0.0025 
ΔsgrS 
ΔmanXYZ  
λattB::tet 
ΔsgrS 0.98 ± 0.04 NS 1.06 ±0.11 NS 
ΔyigL  
λattB::tet WT 0.98 ± 0.07 NS 1.02 ± 0.14 NS 
 
a. See Materials and Methods for detailed procedures. CI, Competition Index, is 
calculated as follows: (log10 strain A output / log10 strain B output)/ (log10 strain A 
input / log10 strain B input).  The data presented are the averages and standard 
deviations of three independent experiments. 
b. Student’s t test was used to compare the output and the inoculums. NS, not 
significant (P ≥ 0.05). 
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Table 3.3 Competition assays to measure the effects of sgrS mutations on growth 
with αMG in minimal MOPS medium with glycerol 
E. coli strain A 
genotype  
E. coli strain B 
genotype 
-αMG + 0.5% αMG 
CIa (n=3) p-valueb CIa (n=3) p-valueb 
λattB::tet WT 0.94 ± 0.04 NS 1.04 ± 0.06 NS 
ΔsgrS 
λattB::tet WT 0.98 ± 0.1 NS 0.38 ± 0.11 < 0.0001 
sgrS1manXYZ 
λattB::tet WT 1.03 ± 0.12 NS 0.42 ± 0.06 0.014 
sgrS28ptsG 
λattB::tet WT 0.96 ± 0.3 NS 0.34 ±0.02 0.022 
sgrS26ptsG,yigL 
λattB::tet WT 0.92 ± 0.07 NS 0.5 ± 0.03 0.015 
 
sgrS1manXYZ 
λattB::tet ΔsgrS 0.96 ± 0.13 NS 1.01 ± 0.19 NS 
sgrS26ptsG,yigL 
λattB::tet ΔsgrS 1.1 ± 0.51 NS 1.86 ± 0.64 0.023 
sgrS28ptsG 
λattB::tet ΔsgrS 0.93 ± 0.21 NS 1.11 ± 0.16 NS 
sgrS26ptsG,yigL 
λattB::tet sgrS1manXYZ 1.03 ± 0.06 NS 1.75 ± 0.13 0.019 
sgrS28ptsG 
λattB::tet sgrS1manXYZ 0.91 ± 0.12 NS 1.02 ± 0.1 NS 
sgrS26ptsG,yigL 
λattB::tet sgrS28ptsG 1.03 ± 0.11 NS 2.09 ± 0.25 0.02 
 
a. See Materials and Methods for detailed procedures. CI, Competition Index, is 
calculated as follows: (log10 strain A output / log10 strain B output)/ (log10 strain A 
input / log10 strain B input).  The data presented are the averages and standard 
deviations of three independent experiments. 
b. Student’s t test was used to compare the output and the inoculums. NS, not 
significant (P ≥ 0.05). 
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Table 3.4 Competition assays to measure the effects of mutations in the three sgrS 
targets on growth with aMG in minimal MOPS medium with glycerol 
E. coli  strain A  
genotype 
E. coli  strain 
B genotype 
-αMG + 0.5% αMG  
CIa (n=3) p-valueb CIa (n=3) p-valueb 
ΔptsG 
λattB::tet WT 1.02 ± 0.15 NS 2.87 ± 0.12 0.0008 
ΔmanXYZ 
λattB::tet WT 0.98 ± 0.11 NS 1.02 ± 0.008 NS 
ΔsgrS ΔptsG 
λattB::tet ΔsgrS 0.97 ± 0.02 NS 2.23 ± 0.46 0.04 
ΔsgrS 
ΔmanXYZ 
λattB::tet 
ΔsgrS 0.97 ± 0.12 NS 0.97 ± 0.07 NS 
ΔyigL 
λattB::tet WT 1.01± 0.02 NS 0.26 ± 0.06 0.031 
ΔyigL 
λattB::tet ΔsgrS 0.98 ± 0.04 NS 1.0 ± 0.11 NS 
 
a. See Materials and Methods for detailed procedures. CI, Competition Index, is 
calculated as follows: (log10 strain A output / log10 strain B output)/ (log10 strain A 
input / log10 strain B input).  The results presented here are the averages and 
standard deviations of three independent experiments. 
b. Student’s t test was used to compare the output and the inoculums.  NS, not 
significant (P ≥ 0.05). 
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Table 3.5 Competition assays to measure the effects of sgrS mutations on growth 
with 2DG in minimal MOPS medium with fructose 
E. coli  strain A  
genotype 
E. coli  strain B 
genotype 
-2DG + 0.5% 2DG  
CIa (n=3) p-valueb CIa (n=3) p-valueb 
λattB::tet WT 0.84 ± 0.11 NS 0.84 ± 0.3 NS 
ΔsgrS 
λattB::tet WT 1.09 ± 0.14 NS 0.46 ± 0.1 0.023 
sgrS1manXYZ 
λattB::tet WT 0.97 ± 0.16 NS 1.03 ± 0.13 NS 
sgrS28ptsG 
λattB::tet WT 1.00 ± 0.15 NS 0.68 ± 0.04 0.01 
sgrS1manXYZ 
λattB::tet ΔsgrS 0.98 ± 0.22 NS 2.25 ± 0.59 0.015 
sgrS28ptsG 
λattB::tet ΔsgrS 0.96 ± 0.11 NS 1.12 ± 0.34 NS 
sgrS28ptsG 
λattB::tet sgrS1manXYZ 1.01 ± 0.06 NS 0.59 ± 0.08 0.019 
 
a. See Materials and Methods for detailed procedures. CI, Competition Index, is 
calculated as follows: (log10 strain A output / log10 strain B output)/ (log10 strain A 
input / log10 strain B input).  The results presented here are the averages and 
standard deviations of three independent experiments. 
b. Student’s t test was used to compare the output and the inoculums. S, significant 
(P < 0.05); NS, not significant (P ≥ 0.05). 
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Table 3.6 Competition assays to measure the effects of mutations in the three sgrS 
targets on growth with 2DG in minimal MOPS medium with fructose 
E. coli  strain A  
genotype 
E. coli  strain 
B genotype 
-2DG + 0.5% 2DG 
CIa (n=3) p-valueb CIa (n=3) p-valueb 
ΔptsG 
λattB::tet WT 1.03 ± 0.15 NS 0.98 ± 0.008 NS 
ΔmanXYZ 
λattB::tet WT 0.99 ± 0.06 NS 2.04 ± 0.12 0.003 
ΔsgrS ΔptsG 
λattB::tet ΔsgrS 0.96 ± 0.14 NS 1.08 ± 0.07 NS 
ΔsgrS 
ΔmanXYZ 
λattB::tet 
ΔsgrS 1.02 ± 0.11 NS 1.90 ± 0.27 0.04 
ΔyigL 
λattB::tet WT 0.97± 0.10 NS 0.92 ± 0.08 NS 
 
a. See Materials and Methods for detailed procedures. CI, Competition Index, is 
calculated as follows: (log10 strain A output / log10 strain B output)/ (log10 strain A 
input / log10 strain B input).  The results presented here are the averages and 
standard deviations of three independent experiments. 
b. Student’s t test was used to compare the output and the inoculums.  NS, not 
significant (P ≥ 0.05). 
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CHAPTER 4:  REGULATION AND FUNCTION OF SETA DURING GP STRESS 	  	  
4.1 Introduction 
The gene located 27 nt upstream of sgrS on the E. coli K12 chromosome and 
transcribed in the same orientation is setA.  In numerous enteric bacterial species that 
contain SgrS homologs, setA is present in this position relative to sgrS (Fig. 4.1).  In vitro 
studies of SetA revealed that it is a proton motive force-driven efflux pump capable of 
transporting a wide range of substrates, including various sugars and sugar analogs (67).  
Based on the biochemical characterization, it was plausible to speculate that SetA might 
function in vivo as sugar efflux pumps with roles in carbohydrate metabolism or 
metabolic stress such as GP stress.  The conservation of the sgrR/sgrS/setA gene 
organization was also consistent with the notion that SetA might play a role in GP stress.   
Furthermore, the short intergenic region between sgrS and setA also suggested the 
possibility that the two genes might form an operon. 
In this chapter we show that under stress conditions, setA is coexpressed with sgrS 
in an SgrR-dependent manner.  The setA mutant has a growth defect under stress 
conditions that is medium dependent.  The growth defect can be complemented by SetA 
in trans, confirming that SetA contributes to optimal cellular recovery from stress under 
some circumstances.  The setA mutation also affects the stress-responsive activation of 
sgrS in a medium-specific manner, suggesting that SetA activity affects signaling through 
SgrR.  Efflux assays using radiolabeled αMG indicate that SetA does not play a 
significant role in directly pumping out this sugar analog.  Together, these data suggest 
that SetA plays a complex role in the stress response. 
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4.2 Results 
4.2.1 setA expression is induced in an SgrR-dependent manner under GP stress 
conditions 
In order to determine the involvement of setA in the glucose-phosphate stress 
response, we first examined the expression of setA under stress conditions.  A setA′-lacZ 
fusion was constructed on the chromosome at the setA locus in a Δlac host strain as 
described in Materials and Methods.  In the presence of αMG, the setAʹ′-lacZ fusion was 
activated ~10 fold over the nonstress level (Fig. 4.2B, WT), demonstrating that setA is 
indeed induced in response to the stress. 
The gene located 27 nt upstream of setA on the E. coli K12 chromosome and 
transcribed in the same orientation is sgrS, which encodes the sRNA required for 
recovery from glucose-phosphate stress.  In many organisms that contain SgrS homologs, 
setA is present in this position relative to sgrS (Fig. 4.1).  Our previous work (132) and 
data in Fig. 4.2B demonstrated that expression of sgrS and setA is induced under the 
same stress conditions.  Based on what is known about sgrS regulation, we predicted that 
SgrR (133), the transcriptional activator of sgrS, would also regulate setA.  To elucidate 
the role of SgrR in regulation of setA, a ΔsgrR::cm allele was introduced into the strain 
carrying the setA′-lacZ fusion.  As shown in Fig. 4.2B (ΔsgrR::cm), the absence of SgrR 
did not affect the basal level of setAʹ′-lacZ activity in the absence of stress but abolished 
activation following the exposure of cells to αMG.  This result demonstrated that SgrR is 
required for stress-dependent induction of setA transcription. 
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Previous studies defined a conserved region between positions −70 and −55 
relative to the start of sgrS transcription as required for the SgrR-dependent activation of 
sgrS (130).  To determine whether the same region is needed for the SgrR-mediated 
activation of setA, a 5-bp substitution in this region on the chromosome was constructed 
in the context of the setA′-lacZ chromosomal fusion.  This 5-bp substitution (Fig. 4.2A, 
sub1) was shown previously (133) to disrupt the interaction between SgrR and the sgrS 
promoter and, consequently, to eliminate the SgrR-dependent activation of sgrS.  
Compared with the wild-type fusion, the mutant fusion had a similar basal activity in the 
absence of the stress.  The sub1 mutant fusion was not activated upon exposure of cells to 
αMG (Fig. 4.2B, sub1), indicating that this SgrR-binding site is crucial for stress-
dependent induction of setA.  Similarly, point mutations in the −10 region of the sgrS 
promoter (Fig. 4.2A, sub2) that abrogate sgrS activation in response to glucose-phosphate 
stress (data not shown) also prevented the activation of the setAʹ′-lacZ fusion under stress 
conditions (Fig. 4.2B, sub2). Together, these results suggested that the stress-responsive 
induction of setA was due to SgrR-dependent activation at the sgrS promoter 
4.2.2 setA is co-expressed with sgrS under GP stress conditions 
Based on the setA′-lacZ fusion data (Fig. 4.2), we predicted that sgrS and setA are 
cotranscribed under glucose-phosphate stress.  To confirm this, RT-PCR was performed 
on total RNA from wild-type cells in the presence and absence of αMG.  Using an sgrS-
specific primer and a setA-specific primer (Fig. 4.3A), an amplicon of the expected size 
of ∼150 bp, encompassing the sgrS-setA intergenic region, was produced (Fig. 4.3B).  
Levels of this product were reproducibly higher in samples from wild-type stressed cells 
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than in nonstressed cells (Fig. 4.3B, WT, compare −αMG and +αMG).  Though this is 
semiquantitative RT-PCR, the fact that an sgrS-setA product was detected at high levels 
in stressed wild-type cells was consistent with the setAʹ′-lacZ fusion results (Fig. 4.2).  
This indicated that sgrS and setA are cotranscribed and both are upregulated under 
glucose-phosphate stress conditions.  To further support the results of setAʹ′-lacZ fusions, 
RT-PCR was performed on total RNA from the sgrR mutant (Fig. 4.3B, ΔsgrR::cm), as 
well as the two sgrS promoter mutants (Fig. 4.3B, sub1 and sub2).  The results showed 
lower abundance of the sgrS-setA product in stressed cells carrying the sgrR sub1 or sub2 
mutation compared with stressed wild-type cells, supporting the notion that the stress-
responsive activation of setA requires SgrR and sgrS promoter determinants. 
Transcriptional fusions (Fig. 4.2) and RT-PCR (Fig. 4.3) demonstrate that when 
transcription at the sgrS promoter is activated, some transcripts initiating at PsgrS read 
through the sgrS terminator into setA.  However, it was also possible that an additional 
setA-specific promoter was responsible for the basal transcription of setA′-lacZ.  To 
identify any additional setA transcription initiation sites, 5ʹ′ RACE (8) was performed on 
RNA harvested from stressed (+αMG) and unstressed (−αMG) wild-type cells.  The only 
setA-specific product obtained in this experiment was one that initiated at the previously 
mapped SgrS 5ʹ′ end (data not shown and reference (132)).  Therefore, if another setA-
specific promoter exists, these transcripts must be present at levels too low to detect by 5ʹ′ 
RACE.  Together, these analyses indicate that under glucose-phosphate stress, setA is 
cotranscribed with sgrS from the sgrS promoter, and these two genes form an operon.  
The basal level of fusion activity (Fig. 4.2B) and the product observed in RT-PCR (Fig. 
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4.3B) in samples from the nonstressed cells may originate from a transcription start site 
that could not be detected in our experiments or may represent the basal level of 
expression from the sgrS promoter. 
4.2.3 crp and kdgR mutations affect signaling through the GP  stress response 
The experiments described above established that transcription of the sgrS-setA 
bicistronic transcript initiates at the sgrS promoter under glucose-phosphate stress 
conditions.  In studies of sotA, a SET family member in D. dadantii, the global regulators 
CRP and KdgR were implicated in transcriptional regulation.  CRP activated expression 
of sotA (21), while KdgR, which represses transcription of many genes involved in 
transport and catabolism of 2-keto-3-deoxygluconate in E. coli (84, 97), was shown to 
weakly repress the expression of sotA in D. dadantii (110). We therefore tested the 
effects of CRP and KdgR on regulation of sgrS and setA in E. coli.  Given the evidence 
presented above regarding the coregulation of sgrS and setA (Fig. 4.2 and 4.3), we 
reasoned that CRP and KdgR might regulate setA through one of two mechanisms.  First, 
these regulators might directly bind upstream of the sgrS promoter and directly activate 
or repress sgrS-setA expression.  Second, these regulators could alter sgrS-setA 
expression indirectly by modulating the signal that results in SgrR-mediated activation at 
the sgrS promoter. To determine whether CRP and KdgR were involved in one of these 
modes of regulation, activities of setA′-lacZ and sgrSʹ′-lacZ fusions were monitored in 
two different host strains: host 1, an sgrR+ host in which stress was induced by addition 
of αMG to cultures, and host 2, a ΔsgrR host complemented with a stress signal-
independent sgrR allele (i.e., an sgrR mutant that does not require stress to activate the 
sgrS promoter).  This sgrR1 allele encodes a glycine-to-glutamate substitution at position 
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118 of SgrR; the sgrR1 plasmid promotes sgrS transcription independent of glucose-
phosphate stress conditions (Fig. 4.4D, WT).  If crp or kdgR mutations have an effect on 
regulation of fusions in the context of both host 1 and host 2, it would suggest direct 
regulation.  On the other hand, if crp or kdgR mutations have an effect on regulation of 
fusions in host 1 but not host 2, it would indicate an indirect mechanism of regulation via 
effects on signaling through SgrR. 
Δcrp::cm and ΔkdgR::FRT alleles were introduced into the hosts described above 
carrying the setA′-lacZ fusion.  In the sgrR+ host, the kdgR mutation did not cause a 
significant change in the basal level of setA expression (Fig. 4.4A, −αMG).  The level of 
setAʹ′-lacZ activity in stressed cells (Fig. 4.4A, +αMG) was reproducibly slightly higher 
in the ΔkdgR mutant than in the kdgR+ strain, suggesting that KdgR may play a very 
modest role in regulating setA expression.  The crp mutation resulted in a basal level of 
setAʹ′-lacZ activity that was 2.4-fold higher than in the wild-type strain (Fig. 4.4A, 
−αMG), suggesting that CRP represses setA expression under nonstress conditions.  
Upon exposure of the Δcrp mutant cells to αMG, setAʹ′-lacZ expression increased ~2.4-
fold compared to nonstressed Δcrp mutant cells, though the induced level of setAʹ′-lacZ 
activity in the Δcrp mutant was lower than in the wild-type strain (Fig. 4.4A, +αMG).  
These results suggested that during glucose-phosphate stress, CRP might exert a slight 
effect on stress-responsive activation of setA expression. 
To address whether the slight effects of the crp and kdgR mutations on setAʹ′-lacZ 
expression were direct or through effects on signaling through SgrR, we repeated the 
experiments described above in the ΔsgrR host carrying the stress signal-independent 
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sgrR1 plasmid.  In the wild-type background, the sgrR1 plasmid caused a 3.2-fold 
increase in the level of setAʹ′-lacZ activity over the vector control levels.  sgrR1 plasmid-
containing cells had ~3.3-fold-increased setAʹ′-lacZ activity compared to vector control-
containing cells in the ΔkdgR mutant background (Fig. 4.4B, ΔkdgR::FRT and pPsgrR-
sgrR1).  Consistent with our previous observation (Fig. 4.4A, −αMG), setAʹ′-lacZ activity 
was ~2.2-fold higher in the Δcrp mutant than in the wild type when both strains carried 
the vector control, i.e., the basal level of activity was higher in the absence of CRP (Fig. 
4.4B, Δcrp::cm/vector).  sgrR1 plasmid-containing cells had ~2-fold-increased setAʹ′-lacZ 
activity compared to vector control-containing cells in the Δcrp mutant background (Fig. 
4.4B, Δcrp::cm and pPsgrR-sgrR1).  Importantly, cells carrying the sgrR1 plasmid had 
similar levels of setAʹ′-lacZ expression in wild-type and ΔkdgR and Δcrp mutant 
backgrounds independent of glucose-phosphate stress.  Together, these results suggest 
that while CRP may repress basal levels of setA transcription, neither CRP nor KdgR is 
likely to exert any direct effect on setA transcription under stress conditions. 
Since expression of setA under stress conditions depends on the sgrS promoter, 
we also tested the effects of KdgR and CRP on an sgrS′-lacZ promoter fusion harbored at 
the λattB site.  In addition to wild-type, kdgR and crp mutant strains, the activity of the 
sgrS′-lacZ fusion was also monitored in ΔsgrR and sgrS1 (137) mutant hosts.  The SgrS1 
molecule is defective for regulation of ptsG under glucose-phosphate stress (53) and is 
more sensitive to αMG than the wild-type strain.  Upon exposure to αMG, the sgrSʹ′-lacZ 
fusion in the wild-type strain was induced ~20-fold (Fig. 4.4C, WT) whereas the 
ΔsgrR::cm mutation completely abolished induction, as observed previously (132).  As 
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expected, fusion activity in the sgrS1 mutant was significantly higher than that of the 
wild-type strain (induced ~47-fold) (Fig. 4.4C), because this mutant cannot reduce uptake 
of αMG by downregulating the glucose transporter ptsG mRNA.  Interestingly, the 
induced level of sgrSʹ′-lacZ activity in the ΔkdgR mutant was also higher than in the wild-
type strain (induced ~32-fold) (Fig. 4.4C), although the basal expression levels were 
similar in the two strains, suggesting that KdgR functions as a repressor for the stress-
dependent induction of sgrS expression.  For the crp mutant, basal levels of expression of 
sgrSʹ′-lacZ were similar to those in the wild-type strain.  When stress was induced with 
αMG, sgrS transcription was induced by 3-fold in the crp mutant compared to 20-fold in 
the wild-type strain (Fig. 4.4C). This result suggested that CRP is required for optimal 
induction of sgrS under stress conditions. 
To investigate whether KdgR and CRP directly or indirectly regulate sgrS 
promoter activity, we again utilized the plasmid carrying the sgrR1 mutant allele.  In the 
wild-type strain carrying the sgrR1 plasmid, sgrSʹ′-lacZ activity was increased ~22-fold 
compared to the vector control strain (Fig. 4.4D, WT). Both basal (vector control) and 
induced (sgrR1) levels of sgrSʹ′-lacZ activity in the kdgR and crp mutants were very 
similar to those in the wild-type cells (Fig. 4.4D).  Collectively, these results suggested 
that under glucose-phosphate stress conditions, KdgR represses the activation of sgrS 
(and very slightly of setA) indirectly by altering signaling through the stress response 
system and therefore activity of SgrR.  Similarly, the effect of CRP on the induced level 
of setA and sgrS transcription was mediated through SgrR-dependent signaling.  
Interestingly, CRP had an SgrR-independent effect on the basal level of setA 
transcription, but not on sgrS.  This suggested that there might be a small direct effect of 
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CRP on regulation of an unidentified promoter present in the setAʹ′-lacZ but not the sgrSʹ′-
lacZ fusion. 
4.2.4 A setA mutation causes a defect in recovery from growth inhibition by αMG 
After establishing that setA is activated during glucose-phosphate stress, its role in 
the stress response was investigated.  The growth of wild-type (CS168) and ΔsetA::cm 
mutant (YS143) strains was monitored before and after they were exposed to αMG.  No 
growth differences between the two strains were apparent in LB medium with or without 
αMG (data not shown).  We have noticed in the course of other studies that wild-type and 
sgrS mutant strains have more pronounced growth defects when stress is induced in 
minimal medium compared with LB (Chapter 3).  Therefore, the stress phenotypes of 
wild-type and ΔsetA::cm cells were also tested in minimal MOPS medium with fructose 
or glycerol as a carbon source. In minimal MOPS-fructose medium, the ΔsetA::cm 
mutant strain carrying the vector control (Fig. 4.5A, ΔsetA::cm/vector) had a subtle but 
reproducible phenotype: a longer lag following addition of αMG to the culture than the 
wild-type strain (Fig. 4.5A , WT/vector).  The setA+ plasmid (pZEYS1, where expression 
of setA was controlled by a Ptet promoter) eliminated the lag and restored the growth of 
the ΔsetA::cm strain to a pattern very similar to that of wild-type cells (Fig. 4.5A, 
ΔsetA::cm/pPLtetO-1-setA).  In minimal MOPS medium with glycerol as the carbon source, 
the growth defect of the ΔsetA::cm mutant compared with the wild type was more 
pronounced (Fig. 4.5B) and was similar to the sgrS1 mutant (Fig. 4.5C), which is 
defective in base pairing and subsequent regulation of ptsG during glucose-phosphate 
stress (53).  After stress was induced, the setA mutant strain failed to recover to the wild-
type level even after being cultured overnight.  The effect of the setA mutation under 
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these conditions was bacteriostatic rather than bactericidal (data not shown).  Again, the 
plasmid carrying PLtetO-1-setA complemented the stress-related growth defect of the setA 
mutant (Fig. 4.5B).  These data supported our hypothesis that, at least under some growth 
conditions, SetA plays a role in allowing cells to recover from glucose-phosphate stress.  
On the other hand, in both media, the setA+ plasmid failed to complement the stress 
phenotypes of the sgrS1 mutant (Fig. 4.5C).  This indicates that the sgrS1 phenotype is 
not due to polarity on setA and, further, that the role of SgrS in the stress response cannot 
be substituted for by the activity of SetA. 
4.2.5 The setA mutation affects signaling through SgrR 
Our original hypothesis was that under stress conditions, SetA facilitates removal 
of nonmetabolizable sugars, for example, αMG-6-phosphate, by pumping them out.  If 
this were true, we would expect to see differences in signaling through SgrR in a setA 
mutant compared to the wild-type strain.  Since sgrS transcription is controlled by SgrR 
(132, 133) (Fig. 4.4C), we measured signaling through SgrR using the sgrS′-lacZ fusion. 
The activation of the fusion in wild-type and ΔsetA::cm backgrounds was compared to 
activation in a ΔsgrS strain, where stress and sgrSʹ′-lacZ transcription are increased 
because the stress response is defective.  This experiment was performed in minimal 
MOPS medium with fructose or glycerol as a carbon source. In minimal MOPS-glycerol 
medium, basal expression levels (−αMG) of the sgrSʹ′-lacZ fusion were similar in the 
wild type and the ΔsetA mutant.  In wild-type cells, sgrSʹ′-lacZ was induced by ~2.8-fold 
upon exposure to αMG, while induction in the ΔsetA mutant was ~5.6-fold (Fig. 4.6A).  
The activation of sgrSʹ′-lacZ was induced by ~8.8-fold in the ΔsgrS mutant.  This 
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suggested that the ΔsetA mutation impairs the stress response and therefore increases 
stress signaling through SgrR, though to a lesser degree than the ΔsgrS mutation.  In 
minimal MOPS-fructose medium, however, both the basal and induced levels of sgrSʹ′-
lacZ expression in the ΔsetA::cm mutant were very similar to those of the wild type, 
while the sgrS mutant showed higher induction (Fig. 4.6B).  The differential phenotypes 
in the two media were reminiscent of the growth experiments (Fig. 4.5) in that the effect 
of the setA mutation was more dramatic in minimal glycerol medium than in minimal 
fructose medium.  Together, these results suggested that the setA mutation affects 
signaling through SgrR in a medium-specific manner. 
4.2.6 Efflux of αMG by the cells is independent of SetA 
To directly test the hypothesis that SetA promotes efflux of αMG under stress 
conditions, the efflux of 14C-labeled αMG from wild-type and ΔsetA::cm mutant cells 
was monitored using an assay described previously (141).  αMG was implicated as an in 
vitro substrate for SetA in a previous study (67).  We reasoned that if SetA is the major 
transporter responsible for removing the nonmetabolizable sugar from the cells during 
stress, the setA mutant would exhibit an elevated steady-state intracellular αMG level 
compared to that of the wild-type strain and would also show slowed kinetics of αMG 
efflux.  Since ManXYZ and PtsG are the two main transporters responsible for αMG 
uptake in E. coli (96), a ΔmanXYZ ΔptsG mutant was also included in the experiment as 
a negative control.  All strains were grown in minimal MOPS-glycerol medium and 
stressed with [14C]αMG.  These are the conditions under which the setA mutant had the 
strongest growth phenotype (Fig. 4.5B).  After 20 min of incubation, the cells were 
diluted into fresh medium lacking [14C]αMG to promote efflux.  As shown in Fig. 4.7, the 
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steady-state level of cell-associated radioactivity in wild-type cells at time zero 
(immediately upon dilution) was ~10-fold higher than in the αMG uptake mutant (ΔptsG 
ΔmanXYZ).  In wild-type cells, cell-associated counts decreased rapidly in the first 10 
min following dilution and leveled out at a new, lower steady state.  This result resembles 
the pattern reported in other, similar SetA efflux studies (27).  The ΔsetA::cm mutant 
showed a steady-state level of cell-associated radioactivity that was nearly identical to the 
level in wild-type cells.  Moreover, the pattern of [14C]αMG efflux for the ΔsetA::cm 
mutant was also very similar to that of the wild-type cells, suggesting that SetA does not 
function as the major αMG efflux pump under these stress conditions. 
4.3 Discussion 
In this chapter, we show that under GP stress conditions, setA is coexpressed with 
sgrS (Fig. 4.2 and 4.3).  Our data are consistent with an operonic arrangement for sgrS 
and setA, with transcription initiating upstream of sgrS at a promoter that is activated 
under stress conditions by the transcription factor SgrR.  Most well-characterized sRNA 
genes to date are transcribed independently (140), but a few cases have been documented 
where sRNA expression seems to be related to expression of flanking protein-encoding 
genes.  For example, the recently identified spd-sr37 and ccnA in Streptococcus 
pneumoniae (126) and pel/sagA in group A streptococcus (73) are cotranscribed with 
downstream protein-coding genes.  In E. coli, a previous study identified several sRNAs, 
e.g., SroC, which may be products of transcriptional attenuation of downstream genes 
and other sRNAs, e.g., SroD and SroE, that are likely processed from longer mRNAs 
(135).  6S RNA in E. coli is also processed from a bicistronic RNA, but it is a protein-
binding sRNA (140) rather than a base-pairing sRNA like SgrS.  The promoter of ryhB, 
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which encodes an Hfq-dependent sRNA in E. coli that regulates various genes involved 
in iron metabolism (74), was implied to control the expression of the downstream gene 
yhhX (134).  This gene organization is perhaps most analogous to the arrangement 
between sgrS and setA. However, we have clearly demonstrated here that, unlike YhhX, 
which encodes a putative D-galactose-1-dehydrogenase (103) whose functional link to 
RyhB is unclear, SetA contributes to the same stress response system as SgrS (Fig. 4.5). 
The presence of a putative rho-independent sgrS terminator strongly suggests that 
bicistronic sgrS-setA transcripts are generated by readthrough of the sgrS terminator.  
This is reminiscent of the case reported in group A streptococcus where a Rho-
independent terminator between the sRNA coding gene pel/sagA and the downstream 
gene allowed and regulated the readthrough (87).  Northern blots using a setA-specific 
probe did not yield a signal at the size predicted for the sgrS-setA transcript even under 
stress conditions (data not shown), whereas a strong ∼200-nt signal was seen for SgrS 
using an SgrS-specific probe under stress conditions (132).  Real-time PCR experiments 
revealed that under GP stress, steady-state levels of the sgrS transcript are ~600-fold 
higher than those of the sgrS-setA bicistronic transcript (data not shown), highlighting the 
significantly greater abundance of the SgrS RNA than of the bicistronic transcript.  
Collectively, these results suggest that termination usually occurs at the 3ʹ′ end of SgrS 
and rather infrequently transcriptional readthrough produces the bicistronic transcript.  
Alternatively, the sgrS-setA RNA may be very unstable relative to SgrS. 
We cannot rule out an additional setA promoter either within sgrS or further 
upstream.  A basal level of activity for the setA′-lacZ fusion independent of the known 
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sgrS promoter was observed (Fig. 4.2).  Two transcriptional regulators, CRP and KdgR, 
which influence the expression of sotA, encoding a SetA paralog in D. dadantii (21, 110), 
were tested for their roles in regulating setA expression.  A crp mutation increases the 
basal level of setA′-lacZ activity (Fig. 4.4A and B), but not the activity of sgrSʹ′-lacZ, 
suggesting there may be another promoter controlling setA expression that is repressed by 
CRP.  Further analysis of transcriptional regulation of setA may provide additional clues 
to its role in cell physiology. 
Both KdgR and CRP had modest effects on the activation of setA′-lacZ and more 
significant effects on sgrS′-lacZ under stress conditions (Fig. 4.4A and C).  The results of 
experiments using the plasmid-encoded signal-independent SgrR (Fig. 4.4B and D) 
implied that the crp and kdgR mutations alter the ability of wild-type SgrR to sense and 
respond to the stress signal.  In the case of kdgR, its deletion is known to cause 
derepression of eda, which encodes 2-keto-3-deoxy-6-phosphogluconate (KDPG) 
aldolase that cleaves KDPG to pyruvate and triose-3-phosphate (84).  Interestingly, 
pyruvate was reported previously to abrogate the degradation of ptsG in a Δpgi mutant 
(59), usually indicative of altered SgrS levels or function.  Furthermore, addition of 
pyruvate to the growth medium increases sgrSʹ′-lacZ fusion activity in aMG-stressed 
wild-type cells (M. Patel, G. Richards, and C. K. Vanderpool, unpublished data).  It is 
therefore possible that increased endogenous pyruvate concentrations caused by the kdgR 
deletion alter signaling through SgrR and, subsequently, stress-dependent activation of 
sgrS. 
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This study showed that SetA is required for optimal recovery from GP stress 
under certain growth conditions (Fig. 4.5).  The hypothesis that SetA directly pumps out 
nonmetabolizable sugars (at least αMG) was not supported by our efflux experiments 
(Fig. 4.7). Consistent with this result, the stress phenotype exhibited by the sgrS mutant 
could not be bypassed by ectopic expression of setA (from PLtetO-1-setA) (Fig. 4.5C).  This 
demonstrates two important points: i) that the growth defect of an sgrS mutant is not due 
to polarity on setA and ii) that the role of SgrS in the stress response cannot be replaced 
by the activity of SetA, suggesting that SgrS and SetA affect stress recovery by 
fundamentally different mechanisms.  SgrS inhibits production and activity of the αMG 
transporter PtsG (130) and therefore inhibits intracellular αMG6P accumulation.  Since 
SetA cannot compensate for the lack of SgrS activity, it follows that SetA acts at a level 
in the stress response that does not directly impact intracellular αMG6P levels.  This line 
of reasoning is consistent with our efflux data (Fig. 4.7).
SetA is not fully conserved in enterobacterial genomes that encode SgrS (45); for 
example, it is absent in some pathogenic E. coli and Salmonella strains.  While we do not 
currently understand why setA is absent in these organisms, it may be due to potentially 
redundant functions of the other two SET proteins, namely, SetB and SetC, at least one of 
which is encoded in these genomes that lack setA.  SetA shares a high degree of amino 
acid sequence similarity with SetB and SetC (67).  Similar to SetA, SetB was also 
capable of transporting glucose and lactose in vitro, although it had a narrower substrate 
range (67).  The substrate of SetC remains unidentified.  Like setA, the genomic locations 
of these other SET family members suggest involvement in carbohydrate metabolism.  In 
the E. coli K12 genome, setB is located adjacent to the fruBKA operon encoding the 
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major fructose transporter (96), while setC is in close proximity to genes encoding a 
putative galactose-pentose-hexuronide transporter (89).  While transcription of setB and 
setC in E. coli K12 was not induced by GP stress (data not shown), it is possible that in 
organisms that lack setA, SetB or SetC functionally replaces SetA and contributes in a 
similar fashion to the GP stress response. 
SetA is not fully conserved in enterobacterial genomes that encode SgrS (45); for 
example, it is absent in some pathogenic E. coli and Salmonella strains.  While we do not 
currently understand why setA is absent in these organisms, it may be due to potentially 
redundant functions of the other two SET proteins, namely, SetB and SetC, at least one of 
which is encoded in these genomes that lack setA.  SetA shares a high degree of amino 
acid sequence similarity with SetB and SetC (67).  Similar to SetA, SetB was also 
capable of transporting glucose and lactose in vitro, although it had a narrower substrate 
range (67).  The substrate of SetC remains unidentified.  Like setA, the genomic locations 
of these other SET family members suggest involvement in carbohydrate metabolism.  In 
the E. coli K12 genome, setB is located adjacent to the fruBKA operon encoding the 
major fructose transporter (96), while setC is in close proximity to genes encoding a 
putative galactose-pentose-hexuronide transporter (89).  While transcription of setB and 
setC in E. coli K12 was not induced by GP stress (data not shown), it is possible that in 
organisms that lack setA, SetB or SetC functionally replaces SetA and contributes in a 
similar fashion to the GP stress response. 
Future studies are required to more fully elucidate the role of SetA in the glucose-
phosphate stress response in E. coli.  Experiments are under way to determine the bona 
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fide in vivo substrate of SetA, and its identification will no doubt shed new light on the 
physiology of the glucose-phosphate stress response. 
	   89	  
4.4 Figures 
 
Fig. 4.1 Conservation of the sgrR-sgrS-setA gene organization.  Organization of genes 
in the sgrR-sgrS-setA chromosomal region in organisms related to E. coli K12.  The 
directions of gene transcription are indicated by arrows.  
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Fig. 4.2 SgrR-dependent activation of setA expression.  A. Genetic organization of the 
sgrR-sgrS region.  The direction of transcription of the sgrR and sgrS genes are depicted 
by the arrows at the top.  The -35 and -10 promoter elements are indicated by horizontal 
lines above the nucleotide sequences.  The boxed nucleotides show the positions where 
mutations sub1 and sub2 where constructed.  The substituted sequences are shown below 
the wild-type sequence.  B. Cells were grown in LB, and 0.1% αMG was added to half of 
the cultures.  β-galactosidase activity was assayed 45 min after the addition of αMG.  
The error bars indicate the standard deviations of three independent experiments. 
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Fig. 4.3 RT-PCR analysis of sgrS and setA.  A. Schematic diagram showing the 
position of the RT primer and PCR primer within the sgrS-setA region.  B.  Wild-type 
(DJ480), ΔsgrR::cm mutant (CV700), and sgrS promoter mutant sub1 (YS135) and sub2 
(YS137) cells were grown in LB medium at 37°C to an OD600 of ~0.5.  Total RNA was 
prepared from cells before and 10 min after exposure to 0.5% αMG, reverse transcribed, 
and amplified by PCR as described in Materials and Methods.  Control experiments were 
also performed on each sample without addition of the reverse transcriptase, and no PCR 
product was detected in any samples (data not shown). 
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Fig. 4.4 Effects of Crp and KdgR on setA and sgrS expression.  A. Cells were grown 
in LB to an OD600 of ~0.5, and 0.1% αMG was added to half of the cultures.  β-
galactosidase activity was assayed 45 min after the addition of αMG.  B.  Cells were 
grown in LB supplemented with 100µg/ml ampicillin to an OD600 of ~0.5 and assayed for 
β-galactosidase activity.  C. Cells were grown in LB to and OD600 of ~0.5, and 0.001% 
αMG was added to half of the culture.  β-galactosidase activity was assayed 45 min after 
the addition of αMG.  D. Cells were grown in LB supplemented with 100µg/ml 
ampicillin to an OD600 of ~0.5 and assayed for β-galactosidase activity.  The error bars 
indicate standard deviations from three independent experiments. 
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Fig. 4.5 Growth of wild-type and ΔsetA strains in the presence of αMG.  Cells were 
grown at 37°C in minimal MOPS medium supplemented with 1ng/ml aTc, 25µg/ml 
kanamycin, and A. 0.2% fructose or B. & C. 0.4% glycerol to an OD600 of ~0.1, and 
αMG was added to the cultures to a final concentration of 0.5%.  Each graph is 
representative of three independent trials.  
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Fig. 4.6 Effects of setA mutation on sgrSʹ′-lacZ activity in response to αMG.  Cells 
were grown in minimal MOPS medium supplemented with A. 0.4% glycerol or B. 0.2% 
fructose and 0.001% αMG was added to half of the cultures.  β-galactosidase activity 
was assayed 45 min after the addition of αMG. The error bars indicate standard 
deviations from three independent experiments. 
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Fig. 4.7 Effects of setA mutation on the efflux of [14C]αMG.  Wild-type (DJ480), 
ΔsetA::cm (ST101), and ΔmanXYZ::kan ΔptsG::cm mutant (CV107) strains were grown 
at 37°C in minimal MOPS medium supplemented with 0.4% glycerol to an OD600 of ~0.1.  
The cells were incubated with [14C]αMG (3.3µM; 1µCi/ml) at room temperature for 20 
min and then diluted 200-fold with fresh minimal MOPS-glycerol medium.  
Radioactivity was examined at the indicated times as described in Materials and 
Methods.  The error bars indicate the standard deviations of three independent 
experiments.  
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CHAPTER 5:  CONCLUSIONS AND FUTURE DIRECTIONS 	  
All organisms must produce biomass and generate energy from external substrates 
in order to grow.  Microbes have evolved complex regulatory mechanisms to optimize 
uptake and metabolism of glucose, which is a preferred carbon source for many species, 
while avoiding accumulation of unnecessary and potentially toxic metabolites.  A 
metabolic stress known as GP stress arises in E. coli upon cytoplasmic accumulation of 
certain phosphosugars, including glucose analogs αMG and 2DG that cannot be 
metabolized by E. coli, resulting in growth inhibition.  The small regulatory RNA SgrS is 
produced in response to GP stress, and its activity as a post-transcriptional regulator helps 
mitigate the stress and improve cellular growth.  During GP stress, SgrS regulates 
multiple targets through distinct interactions (132).  This work has investigated the 
physiological impact of sRNA regulation of a multi-target regulon under a variety of 
conditions (Chapter 3).  Additionally, it has characterized a sugar efflux transporter SetA, 
which is encoded by the gene immediately downstream of the sgrS gene, for its 
regulation and involvement in the cellular response to GP stress (Chapter 4). 
In Chapter 3, I showed that the importance of SgrS-mediated regulation of 
different targets varies in accordance with the stress conditions.  One stress variable that 
we manipulated was the stress-inducing phosphosugar.  Our results showed that when 
αMG is the stressor, SgrS regulation of ptsG is crucial for continued growth, whereas 
regulation of manXYZ by SgrS becomes vital when cells are stressed by uptake of 2DG.  
In addition, we found that regulation of different SgrS target subsets is required when 
cells are stressed in nutrient-rich versus nutrient-poor environments.  When cells are 
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stressed with αMG during growth in rich media or with 2DG in minimal media, SgrS is 
primarily needed to regulate the mRNAs encoding the relevant sugar transporters.  In 
contrast, when cells were stressed with αMG in minimal media, regulation of ptsG alone 
was no longer sufficient to rescue cell growth.  Instead, our results demonstrated that 
SgrS regulation of the phosphatase mRNA (yigL), as well as other unknown targets is 
also required.  Taken together, our results in Chapter 3 suggest that regulation of only a 
subset of SgrS targets is important in a given environment.  Research to define other 
members of the SgrS regulon is underway, and identification of other SgrS targets will no 
doubt lead to new insights into the physiology of glucose-phosphate stress.  
In Chapter 4, we demonstrated that under GP stress conditions, setA is 
coexpressed with sgrS.  Our data are consistent with an operon arrangement for sgrS and 
setA, with transcription initiating upstream of sgrS at a promoter that is activated under 
stress conditions by the transcription factor SgrR.  However, we still cannot rule out an 
additional setA promoter either within sgrS or further upstream.  Two transcriptional 
regulators, CRP and KdgR, which influence the expression of sotA, encoding a SetA 
paralog in D. dadantii (21, 110), were tested for their roles in regulating setA expression.  
Both KdgR and CRP had modest effects on the activation of setA′-lacZ and more 
significant effects on sgrS′-lacZ under stress conditions.  Further experiments using the 
plasmid-encoded signal-independent SgrR demonstrated that the crp and kdgR mutations 
alter the ability of wild-type SgrR to sense and respond to the stress signal.   
In addition, our results in Chapter 4 showed that SetA is required for optimal 
recovery from GP stress under certain growth conditions.  On the other hand, the results 
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of our efflux experiment suggest that SetA is not responsible for directly pumping out 
nonmetabolizable sugars (at least αMG).  Consistent with this notion, SetA in trans 
cannot compensate for the lack of SgrS activity, suggesting that SetA acts at a level in the 
stress response that does not directly impact intracellular αMG6P levels.   
The conditional nature of the SetA requirement for growth during stress (Chapter 
4) is reminiscent of the phenomenon that both the severity of GP stress-associated growth 
inhibition and regulation of different SgrS targets depends on cellular nutrition status 
(Chapter 3). Our growth experiment in Chapter 3 showed that supplementation of 
Casamino acids to minimal media improves cell growth during GP stress.  These results 
suggested that the amino acid components of the rich media might contribute to the 
reduced severity of stress in this media compared to minimal media.  The underlying 
mechanisms remain unclear.  Perhaps these components help cells cope with GP stress by 
diminishing the drain on central metabolites and/or by lessening energy demand for 
growth.  Preliminary experiments in which different combinations of amino acids, 
nucleosides and vitamins are supplemented to the minimal media showed that some 
improve cell growth during GP stress (at least in wild type cells), whereas others stall 
growth even in wild type cells in a GP stress-dependent fashion (data not shown).   
Interestingly, overexpression of SetA from the plasmid caused more dramatic 
growth inhibition in cells stressed with αMG in minimal media.  This was found to be 
due to an amino acid auxotrophy as a result of the higher expression level of SetA under 
the stress conditions, and can be reversed by supplementing the media with certain amino 
acids or TCA cycle intermediates (Appendix). Together, these results suggested that the 
overexpression of SetA during GP stress might upset the fine balance in the pool size of 
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TCA cycle intermediates, ultimately causing a growth defect.	  	  Although the SetA 
overxpression-associated amino acid auxotrophy may not necessarily share linked 
underlying causes with the phenomenom of nutrient-dependent SgrS regulation of target 
mRNAs, they may provide important clues to the nature of the metabolic problem 
experienced by stressed cells.   
This work sets the stage for future persuit of two important questions: i) what is 
the underlying toxicity of GP stress and ii) what cellular responses, particularly those 
mediated by SgrS, are important for overcoming the stress? Answering the first question 
will require detailed analyses of intracellular metabolite levels and changes in metabolic 
fluxes in response to to GP stress.  On the other hand, answering the second question will 
need identification of other SgrS regulon members and assessment of how their 
regulation contributes to GP stress-associated growth phenotypes.  Both of these are 
under active investigation in our laboratory and will no doubt shed new light on the 
physiology of the GP stress response.  
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APPENDIX 
 
Compound 
Supplementedb 
Cell Growth 
WT 
vector 
WT 
pPLtetO-1setA 
ΔsetA::cm 
vector 
ΔsetA::cm 
pPLtetO-1setA 
1. N/A ++ + ++ + 
2. CAA ++ ++ ++ ++ 
3. Thr + Asp ++ + ++ + 
4. Gln + Asp ++ ++ ++ ++ 
5. Glu + Asp ++ ++ ++ ++ 
6. Gln ++ + ++ + 
7. Aspc ++ + ++ + 
8. Glu ++ ++ ++ + 
9. Glu + succinate ++ Ntd ++ ++ 
10. malate ++ Ntd ++ ++ 
11. Aspe ++ Ntd ++ ++ 
12. OAAf,g ++ ++ ++ ++ 
13. αKGf ++ ++ ++ ++ 
14. OAA + αKGf ++ ++ ++ ++ 
15. Pyruvateh + + + + 
16. PEP ++ ++ ++ ++ 	  
a. All the strains were grown on M63 agar supplemented with 0.4% glycerol, 25µl 
kanamycyin, 10ng/ml aTc, 0.5% αMG. 
b.  The final plate concentration: Glu, 5.0mM; Gln, 5.0mM; Thr, 0.3mM; malate, 
2.7g/liter; succinate, 1g/liter; OAA, 0.05%; αMG, 0.05%. 
c. The concentration of aspartate: 0.05g/liter. 
d.  Nt, not tested. 
e.  The concentration of aspartate: 0.5g/liter. 
f. OAA, oxaceloactate; αKG, α-ketoglutarate. 
g.  All strains growing on OAA grew at similar rates, but much more slowly.  On 
OAA-only plates, cells took 3 days to form colonies compared to only 2 days for 
other “++” substrates. 
h. All	  strains	  growing	  on	  pyruvate	  grew	  at	  similar	  rates,	  but	  all	  exhibited	  αMG-­‐specific	  growth	  retardation. 
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